Florida International University

FIU Digital Commons
FIU Electronic Theses and Dissertations

University Graduate School

11-15-2013

Real-time qPCR Assay Development for Detection
of Bacillus thuringiensis and Serratia marcescens
DNA and the Influence of Complex Microbial
Community DNA on Assay Sensitivity
Jonathan Segal
jonathansegal89@gmail.com

DOI: 10.25148/etd.FI13121204
Follow this and additional works at: https://digitalcommons.fiu.edu/etd
Part of the Biology Commons, Microbiology Commons, and the Molecular Biology Commons
Recommended Citation
Segal, Jonathan, "Real-time qPCR Assay Development for Detection of Bacillus thuringiensis and Serratia marcescens DNA and the
Influence of Complex Microbial Community DNA on Assay Sensitivity" (2013). FIU Electronic Theses and Dissertations. 1030.
https://digitalcommons.fiu.edu/etd/1030

This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in
FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact dcc@fiu.edu.

FLORIDA INTERNATIONAL UNIVERSITY
Miami, Florida

REAL-TIME qPCR ASSAY DEVELOPMENT FOR DETECTION OF BACILLUS
THURINGIENSIS AND SERRATIA MARCESCENS DNA AND THE INFLUENCE OF
COMPLEX MICROBIAL COMMUNITY DNA ON ASSAY SENSITIVITY

A thesis submitted in partial fulfillment of
the requirements for the degree of
MASTER OF SCIENCE
in
FORENSIC SCIENCE
by
Jonathan Segal

2013

	
  

To: Dean Kenneth G. Furton
College of Arts and Sciences
This thesis, written by Jonathan Segal, and entitled Real-time qPCR Assay Development
for Detection of Bacillus thuringiensis and Serratia marcescens DNA and the Influence
of Complex Microbial Community DNA on Assay Sensitivity, having been approved in
respect to style and intellectual content, is referred to you for judgment.
We have read this thesis and recommend that it be approved.
_______________________________________
DeEtta Mills

_______________________________________
Giri Narasimhan

_______________________________________
Kalai Mathee, Major Professor
Date of Defense: November 15, 2013
The thesis of Jonathan Segal is approved.

_______________________________________
Dean Kenneth G. Furton
College of Arts and Sciences

_______________________________________
Dean Lakshmi N. Reddi
University Graduate School

Florida International University, 2013

ii

DEDICATION
I dedicate this thesis to my extraordinary parents, whose selfless support and
unconditional love is beyond words.

iii

ACKNOWLEDGMENTS
I want to express the deepest gratitude to my major professor, Dr. Kalai Mathee,
who graciously took me under her wing. Her unwavering confidence in my abilities
provided me with motivation to be a better scientist and a better human being. If I have
my way, she will be a life-long mentor and will be involved in my future endeavors,
scientific or otherwise.
I wish to acknowledge my committee members, Dr. DeEtta Mills and Dr. Giri
Narasimhan, for their commendable patience and help throughout this project.
Specifically, I would like to thank Dr. DeEtta Mills for the topic-inspiring brainstorming
sessions early in my graduate career and Dr. Giri Narasimhan for his calm, collected
voice of reason and helpful comments.
Finally, I want to thank the past and present members of the Mathee lab crew,
who welcomed me with open arms and taught me so much about science and research.

iv

ABSTRACT OF THE THESIS
REAL-TIME qPCR ASSAY DEVELOPMENT FOR DETECTION OF BACILLUS
THURINGIENSIS AND SERRATIA MARCESCENS DNA AND THE INFLUENCE OF
COMPLEX MICROBIAL COMMUNITY DNA ON ASSAY SENSITIVITY
by
Jonathan Segal
Florida International University, 2013
Miami, Florida
Professor Kalai Mathee, Major Professor
Real-time quantitative polymerase chain reaction (real-time qPCR) assays are an
effective technique to detect biological warfare agents and surrogate organisms. In my
study, primers were designed to detect chromosomal DNA of biological warfare agent
surrogates B. thuringiensis and S. marcescens (representing B. anthracis and Y. pestis,
respectively) via real-time qPCR. Species-level specificity of the primers was
demonstrated through comparisons with a bacterial strain panel and corroborated by
qPCR data. Additionally, the primer efficacy was tested when template DNA was spiked
into metagenomic DNA extracted from clinical lung microbiome samples. The results
showed that while detection of B. thuringiensis or S. marcescens was still largely
successful, the addition of metagenomic DNA did significantly inhibit amplification in
most cases. The present study is significant not only for the design of multiple novel
primer pairs able to detect bacterial agents in metagenomic DNA, but also the
quantitative insight to the influence of background DNA on single species detection at
low DNA concentrations.
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INTRODUCTION
The ubiquity of deoxyribonucleic acid (DNA) and its vital role within living
systems makes it the single most influential molecule in biology. The information carried
by DNA is the fundamental guide for every living organism, from single-cell bacteria to
complex multi-cellular mammals. The uniqueness and universality of DNA has
predicated its usage in many scientific fields. DNA is used in forensic science and
microbial forensics as a means to experimentally individualize the perpetrator of a crime
or to aid in identification of an unknown biological agent. The introduction will discuss
the role of DNA analysis in forensic science and microbial forensics, biological agents
and surrogate organisms, as well as detection techniques.

I. DNA Analysis and Forensic Science

The advent of DNA analysis in the late 20th century has provided the framework
for significant advancements in biology and science. One field that benefitted
tremendously from the arrival of DNA analysis is forensic science, or the practical
application of science to legal investigations and matters of the law. While the pre-DNA
era of forensic science was limited to chemical reactivity, physical evidence examination,
and serology (Li 2008; Butler 2010), modern human DNA typing has provided the tools
to individualize beyond a reasonable doubt. DNA analysis in forensic investigation is
now standard operating procedure (SOP) in crime laboratories, and has gained reputation
in the courtroom as highly compelling evidence (Carey and Mitnik 2002). DNA evidence
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has resulted not only in countless convictions, but also exoneration of the guiltless,
epitomized by the work of the ‘The Innocence Project’ (3).

Evolution of human DNA typing. Forensic DNA typing did not develop in a
vacuum. It is the product of efforts and scientific advances that continue into the present
day. Early forensic biology analyses consisted largely of blood antigen typing and
measuring protein interactions (Li 2008; Butler 2010). Despite these not using DNA
sequence, they exploit the basic concept of polymorphism and provide some power of
identification. While they were fairly successful and can still be used as presumptive tests
today, the probability of obtaining false positives is higher than desired. DNA-based
typing was pioneered by Sir Alec Jeffreys, who developed the variable number tandem
repeat (VNTR) technique in 1984 and used it as forensic evidence in 1985 (Jeffreys et al.
1985). Jeffreys found the human genetic code to be far more polymorphic than any
protein, thus imparting a greater ability to differentiate biological samples (Li 2008).
Specifically, he targeted repeating regions of the DNA that were polymorphic in length
rather than in sequence. The occurrence of length differences in various repeat sequences
is the basis of most DNA typing applications, including Restriction Fragment Length
Polymorphism (RFLP), which relies on restriction enzymes and probes, and techniques
using Polymerase Chain Reaction (PCR) (Reynolds et al. 1991).
Few years after the development of the polymerase chain reaction (PCR) by Kary
Mullis and predecessors in 1993 (Saiki et al. 1988; Mullis 1990; Mullis et al. 1992),
PCR-based typing techniques such as short tandem repeat (STR) assays became the norm
for effective analysis of polymorphic DNA markers (Li 2008). The development of
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techniques such as mitochondrial DNA (mtDNA) typing (Wrischnik et al. 1987; Piercy et
al. 1993), single nucleotide polymorphism (SNP) (Landegren et al. 1998; Wang et al.
1998) assays, and next generation sequencing (NGS) technologies (Mardis 2008;
Schuster 2008; Shendure and Ji 2008; Metzker 2010) are providing even ability to match
crime scene evidence to a perpetrator and represent the progression of the discipline.

The Scientific Working Group on DNA Analysis Methods (SWGDAM) and
Combined DNA Index System (CODIS). Standard Operating Procedures (SOPs) for
modern human DNA typing are developed by the Federal Bureau of Investigation (FBI)
laboratory and maintained for quality assurance by The Scientific Working Group on
DNA Analysis Methods (SWGDAM). SWGDAM works in conjunction with the FBI for
establishing standards and guidelines for DNA analysis (Budowle et al. 1998). Most
notable was the development of the Combined DNA Index System (CODIS) database,
which led the launch of the National DNA Index System (NDIS) under the DNA
Identification Act of 1994 (U.S.C.-14132 1994). CODIS serves as an umbrella term for
all DNA reference repositories at different levels of government, including Local DNA
Index System (LDIS), State DNA Index System (SDIS), and the National DNA Index
System (NDIS). DNA profiles from many sources can be deposited, including convicted
offenders, arrestees, forensic samples, and remains (U.S.C.-14132 1994).
With the exception of mitochondrial DNA (mtDNA), CODIS currently stores
DNA profile information from the 13 core CODIS STR loci. The combined use of these
13 nuclear STR loci (CSF1PO, D3S1358, D5S818, D7S820, D8S1179, D13S317,
D16S539, D18S51, D21S11, FGA, THO1, TPOX, vWA) (Table 1A) and amelogenin for
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sex determination allow for standardized and powerful human identification via allelic
discrimination (Budowle et al. 1998; Butler and Reeder 2013). Biotechnology firms have
created comprehensive kits to amplify all the loci (e.g., AmpFLSTR® Profiler Plus® and
COfiler® kits, Applied Biosystems, Madison, WI) and computer software to streamline
allelic calling (e.g., GeneMapper®, Applied Biosystems, Madison, WI).
Recently, additional loci have also been identified and used to increase
discrimination power and provide additional coverage of the genome in the case of
degraded or limited DNA. The supplementary coverage generally involves the addition of
more loci, such as two pentanucleotide STR loci Penta E and Penta D (Table 1B), which
are now incorporated into commercial kits such as the PowerPlex 16 System (Promega,
Madison, WI) for use in forensic laboratories after proper validation.

Forensic analysis of non-human DNA. DNA from a variety of non-human
sources, including plants, animals, and microorganisms, have proven to be useful sources
of evidence. Documented usage of animal DNA in cases such as the Beamish murder
trial (Menotti-Raymond et al. 1997) and State of Vermont v. Michael J. Demers (Supreme
Court of Vermont 1997) indicate the value of animal DNA in cases, ranging from
murders to poaching. Plant DNA has also been used as scientific evidence in court, such
as in State of Arizona v. Mark Alan Bogan (Court of Appeals of Arizona 1995), where
plant matter helped place connect a murder suspect to the crime scene. Microorganisms
can also play a large role in forensics, notably in soil analysis. DNA profiling of
microbial communities in soil can distinguish soils better than chemical analyses in some
instances (Moreno 2005; Moreno et al. 2006).
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Table 1. STR Loci. A) The 13 core loci of the Combined Index Database System
(CODIS). B) Two additional loci for increased statistical power. All data sourced from
STRBase (Butler and Reeder 2013).
A)

Locus Name!

Repeat Unit!

Chromosomal
Location!

CSF1PO!

TAGA!

5q33.1!

TH01!

TCAT!

11p15.5!

VWA!

[TCTG][TCTA]!

12p13.31!

D5S818!

AGAT!

5q23.2!

FGA!

TPOX!
D3S1358!
D7S820!

4q31.3!

GAAT!

[TCTG][TCTA]!
GATA!

2p25.3!

3p21.31!
7q21.11!

D8S1179!

[TCTA][TCTG]!

8q24.13!

D16S539!

GATA!

16q24.1!

D13S317!
D18551!
D21511!

B)

CTTT!

TATC!

AGAA!

Complex [TCTA]
[TCTG]!

Locus Name!

Repeat Unit!

Penta D!

AAAGA!

Penta E!

13q31.1!
18q21.33!
21q21.1!
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20!
80!
20!
15!
28!
24!
15!
30!
17!
17!
19!
51!
82!

Chromosomal
Location!

Number of
Alleles Known!

15q26.2!

21!

21q22.3 !

AAAGA!

Number of
Alleles
Known!

14!

II. Microbial Forensics and Biological Warfare Agents

The exploitation of biological agents to inflict harm has persisted since antiquity.
Modern biological warfare (20th century – present) is initially thought of in the context of
military application of biological and chemical agents, which began on a large scale in
World War I and II (Tucker and Koblentz 2009). Concerned groups, primarily
governments and regimes, concentrated efforts on research and development of
biological agents. The Biological Weapons Convention of 1972 then banned the
accumulation and storage of bioagents internationally (Tucker and Koblentz 2009). Since
the treaty, research has gravitated towards biodefense in light of the potential usage of
biological weapons by terrorists or undesirables.
The field of microbial forensics developed as a niche subfield that examines
biological agents related to bioterrorism, biological warfare, biosecurity, or accidental
discharge (Budowle et al. 2005; Tucker and Koblentz 2009). Typically, the investigations
intend to identify or confirm the identity of an unknown agent as well as to establish
etiology (Budowle et al. 2005). In its infancy, microbial forensics was dependent on
culturing bacteria and protein analyses for identification of a microorganism (Budowle
2011). However, much like human DNA typing, the advents of PCR and sequence-based
techniques transformed the field. While microbiology techniques are still valuable and
useful, molecular analyses and genetics supply the tools to look past culturable
phenotypes and characterize microorganisms more accurately (Handelsman 2004;
Schmeisser et al. 2007).
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The Center for Disease Control categorizes known biological warfare agents on
the basis of several factors such as ease of dissemination, mortality, and potential for
person-to-person transmission (Table 2). Category A agents are considered more
threatening that Category B or Category C agents. The current list of Category A agents
consists of Bacillus anthracis, Yersinia pestis, Clostridium botulinum, Francisella
tularensis, Variola major, hemorrhagic fever filoviruses (Ebola and Marburg fever), and
hemorrhagic arenaviruses (Lassa fever, Junin, Machupo) (Budowle et al. 2005). These
agents and their associated dangers have prompted scientists to concentrate on those that
pose the highest risk. Research is focused on developing methods to identify these agents,
as rapid and sensitive detection is of utmost importance to minimize potential damage
caused by these agents in the event of an outbreak or attack.

III. Bacillus anthracis, the Causative Agent of Anthrax

Microbial forensics and B. anthracis gained public fame following the ‘AnthraxLetter Event’ bioterrorism attack in 2001 and its subsequent microbiological investigation
(Justice 2010). Between September and October 2001, four confirmed (five suspected)
envelopes with B. anthracis spores were mailed to New York Post, NBC new anchor
Tom Brokaw in New York City, the offices of Senator Tom Daschle and Senator Patrick
Leahy in Washington D.C., and American Media International offices in Boca Raton,
Florida (Rasko et al. 2011). Although none of the intended targets were reached, 11
individuals contracted inhalation anthrax and 11 others contracted cutaneous anthrax
infections, resulting in five deaths (Rasko et al. 2011). The victims were mail handlers or
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Table 2. Description of Center of Disease Control (CDC) Category A and Category B
Bioterrorism Agents. (Budowle et al. 2005)

Name!

Threat!

Type!

Bacillus anthracis!

Anthrax!

Bacterial!

Clostridium botulinum toxin!

Botulism!

Bacterial toxin!

Yersinia pestis!

Plague!

Bacterial!

Variola major virus!

Smallpox!

Viral!

Francisella tularensis!

Tularemia!

Bacterial!

Arenaviruses, Ebola virus,
Lassa virus, Marburg virus!

Viral hemorrhagic fever!

Viral!

Brucella spp.!

Brucellosis!

Bacterial!

Clostridium perfringens toxin!

Epsilon toxin!

Bacterial toxin!

Salmonella spp., Shigella
spp., Escherichia coli
0157:H7!

Food safety threats!

Bacterial!

Burkholderia mallei!

Glanders!

Bacterial!

Burkholderia pseudomallei!

Meliodosis!

Bacterial!

Chlamydia psittaci!

Psittacosis!

Bacterial!

Coxiella burnetti!

Q Fever!

Bacterial!

Ricinus communis toxin!

Ricin!

Plant toxin!

Staphylococcal enterotoxin B!

Enterotoxin!

Bacterial toxin!

Rickettsia prowazekki!

Typhus fever!

Bacterial!

Venezuelan equine virus,
Eastern equine virus,
Western equine virus!

Viral encephalitis!

Viral!

Vibrio cholerae,
Cryptosporidium parvum!

Water safety threats!

Bacterial, Protozal!

CATEGORY A!

CATEGORY B!
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processors, exposed to the anthrax spores at their respective worksites (Jernigan et al.
2001; Jernigan et al. 2002).
The FBI formed a task force and began an in-depth investigation to discover the
responsible party. The investigation, code-named ‘Amerithrax’, was a multi-faceted
inquiry that included genetic analysis of the sporulated B. anthracis strains found in the
envelopes (U.S.D.O.J 2010). The microbiological and genetic investigation compared the
strains found in all of the envelopes to reference strains and too each other. By
comparison of specific mutations, the analysis revealed a single type ‘Ames’ strain in all
of the envelopes, suggesting that all the B. anthracis came from a single source
(U.S.D.O.J 2010).
Prior to the Amerithrax investigation, governments and intelligence agencies had
been dealing with biological warfare threats for decades. One such event that gained little
media coverage in the U.S. was the Kameido Anthrax Incident of 1993 (Takahashi et al.
2004). The Aum Shinrikyo, a radical Japanese sect, aerosolized a liquid suspension of B.
anthracis spores in Tokyo in a rather understated act of terrorism (Budowle et al. 2005).
No people were reported sick or dead from anthrax exposure (Takahashi et al. 2004). As
a result of the event’s inconspicuous nature, only retroactive microbiological examination
in 2000 identified the aerosol liquid as sporulated B. anthracis (Keim et al. 2001). Using
multiple locus variable number tandem repeat analysis (MLVA), a PCR based multi
locus variant of VNTR, analysts identified the isolate as the Sterne strain of B. anthracis,
an attenuated strain commonly used for veterinary vaccinations (Budowle 2011).
The weaponization of B. anthracis was not limited to terrorist groups.
Weaponization of biological agents for warfare is evidenced by events such as the
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Gruinard Island experiments conducted by the British government in 1942 and 1943
(Manchee and Stewart 1988; Inglesby et al. 1999; Spencer 2003). These experiments
involved live testing of ‘N-bombs’ containing sporulated B. anthracis, as well as
development of anthrax-infested cattle cakes intended to wipe out food supplies of Nazi
Germany (Spencer 2003). Additionally, a 1979 outbreak of anthrax poisoning occurred
around a military facility in Sverdlovsk, USSR, killing upwards of 66 people (Meselson
et al. 1994; Jackson et al. 1998; Spencer 2003).

B. anthracis pathogenicity. Bacillus anthracis is a Gram-positive spore-forming
species that operates as an obligate aerobe (Sacchi et al. 2002; Spencer 2003). As a
member of the B. cereus group of bacteria, it is notoriously difficult to distinguish B.
anthracis from other group members by phenotype or 16S rRNA sequencing (Ash et al.
1991; Sacchi et al. 2002; Hadjinicolaou et al. 2009). Conclusive differentiation can be
obtained with amplified fragment length polymorphism (AFLP) (Spencer 2003) or
genome sequencing (Rasko et al. 2011).
Pathogenicity of B. anthracis stems largely from two virulence factor plasmids,
pXO1 and pXO2 (Spencer 2003) (Figure 1). Three components are encoded on the 184.5
kb pXO1 plasmid: an 89-kDa edema factor (EF), an 83-kDa calmodulin-dependent
adenylate cyclase lethal factor (LF), and an 85-kDa protective antigen (PA) that binds to
host cell receptors and facilitates entry into the cell (Little and Ivins 1999; Spencer 2003).
Lethal factor (LF) and edema factor (EF) competitively bind to the protective antigen
(PA), forming lethal toxin or edema toxin, respectively. (Little and Ivins 1999). Research
with mice demonstrates that the lethal toxin is more crucial in virulence, but a synergistic
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effect is observed when both toxins are present (Pezard et al. 1991). Additionally,
regulation of virulence is primarily mediated by atxA, a gene found on pXO1 (Figure 1)
that is required for the transcription of the toxin genes (Bourgogne et al. 2003).
The second 95.3-kb plasmid pXO2 acts in a complementary fashion to pXO1. The
pXO2 plasmid harbors three genes (capA, capB, capC; Figure 1) that are responsible for
production of a protective polyglutamyl capsule that surrounds that bacterium (Makino et
al. 1989; Spencer 2003). The edema, hemorrhage, and necrosis caused by the pXO1 toxin
compounds is exacerbated by the encapsulation and the subsequent inability of the
leukocytes to phagocytose the bacteria. Complete virulence requires both pXO1 and
pXO2, but attenuated strains can be achieved through loss of one or both of the plasmids
(Spencer 2003).

Figure 1. B. anthracis pXO1 and pXO2 plasmids. Green arrows indicate positive
regulation by atxA, red arrows show negative regulation, and blue arrows indicate genes
that are not regulated by atxA. White arrows indicate genes not expressed under the
growth conditions of the study (Bourgogne et al. 2003).
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Anthrax infections. B. anthracis can be introduced into the body through various
routes, including the skin, gastrointestinal tract, or the lungs, resulting in cutaneous
anthrax, gastrointestinal anthrax, or pulmonary anthrax poisoning respectively (Spencer
2003). Cutaneous anthrax is the most common type of infection and also the mildest
(Little and Ivins 1999; Spencer 2003). The infection results in establishment of a papule,
formation of edema, and eventual escharing of the tissue (Figure 2).

Figure 2. Cutaneous anthrax lesion. The dark eschared tissue is typical of a late-stage
anthrax lesion (Steele 1962).
Cutaneous infection can be effectively treated using antibiotics (Little and Ivins
1999). Infections resulting from inhalation or ingestion of anthrax are considered
extremely severe with high risk of septicemia and toxemia (Little and Ivins 1999).
Although uncommon, gastrointestinal anthrax (associated with ingestion of undercooked
or contaminated meat) results in the formation of a papule on the wall of the esophagus,
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stomach, duodenum or ileum (Spencer 2003). Manifesting in severe edema, necrosis, and
the enlargement of mesenteric lymph nodes, the gastrointestinal infection results in
septicemia and death if not treated promplty with antibiotics (Little and Ivins 1999;
Spencer 2003).
Perhaps the most serious and infamous type of anthrax infection is pulmonary
anthrax, initiated with the deposition of sporulated B. anthracis within the alveolar spaces
of the lungs (Spencer 2003). The spores are unintentionally transported to lymph nodes
by phagocytic leukocytes (the protective capsule prevents destruction within the
phagocyte) and germinate within the lymph nodes (Little and Ivins 1999; Spencer 2003).
Once in the vegetative state, the bacterial load increases and bacteria can eventually enter
the bloodstream, resulting in severe septicemia and death unless treated early powerful
antibiotics (Little and Ivins 1999; Spencer 2003).

IV. Yersinia pestis, the Causative Agent of Plague

Yersinia pestis, the causative agent of plague, can be transferred from infected
rodents to humans via flea vectors. Outbreaks of bubonic plague and pneumonic plague
have proven fatal to countless people throughout history. Although the numbers are
uncertain, some estimate that 200 million people have died during the course of recorded
history as a result of infection by Y. pestis (Perry and Fetherston 1997). Responsible for
most of these deaths were several massive pandemics, including the Justinian plague (6th8th century), the ‘Black Death’ plague (14th-19th century), and the unnamed third
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pandemic, beginning in the Yunnan province of China in 1855 (19th-20th century) (Perry
and Fetherston 1997; Parkhill et al. 2001; Haensch et al. 2010).
The wrath of plague is not purely historical; recent events have again shown the
remarkable ability of Y. pestis to infect humans. In 1994, a major outbreak of pneumonic
plague occurred in Surat, India claimed the lives of 56 people (Dennis 1994). The plague
was believed to have originated from less severe bubonic cases reported to the World
Health Organization (WHO) in neighboring Maharashtra (Dennis 1994). The outbreak
was eventually controlled when treatment with tetracycline hydrochloride proved
effective and was administered to patients en masse (Nandan 1994). Other outbreaks
arose as recently as 2003 in Algeria (Bertherat et al. 2007) and 2009 in Libya (Cabanel et
al. 2013). Although outbreaks like these have occurred recently and frequently, the
availability of effective antibiotics in the past several decades has significantly reduced
the impact of the disease on human populations (Cabanel et al. 2013). As a consequence
of the deadly effects of plague infection in humans, Y. pestis is also considered to have
dangerous potential as a biological warfare agent (Prentice and Rahalison 2007). One
example of such activity include the conduction of Y. pestis –infected flea bomb trials by
the Japanese military on prisoners of war from 1930s until World War II (Prentice and
Rahalison 2007). Moreover, reports of former Soviet scientists alluded to an attempt by
the USSR to produce multi-drug resistant Y. pestis for use as a biological warfare agent
during the Cold War era (Kadlec et al. 1997).

Y. pestis pathogenicity. Yersinia pestis is a Gram-negative non-spore forming
coccobacillus that operates as a facultative anaerobe (Perry and Fetherston 1997). As a
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member of both the Enterobacteriaceae family and Yersinia genus, it is closely related to
other pathogenic Yersinia species such as Y. pseudotuberculosis, and Y. enterocolitica. Y.
pestis also has a unique set of metabolic growth requirements that require a semi-parasitic
relationship with a host (Perry and Fetherston 1997).
The pathogenicity of Y. pestis is well characterized. Its facultative parasitic
lifestyle lends to its ability to successfully evade host defenses in many complex ways
(Parkhill et al. 2001; Prentice and Rahalison 2007). Because of its complexity, only select
virulence factors will be discussed here. Y. pestis derives is pathogenicity principally
from three plasmids (Figure 3), the 100–110 kb pMT1 (or pFra), the 70-kb pCD1 and the
9.5 kb pesticin plasmid (pPCP1) (Kingston et al. 2007). The pMT1 and pCD1 plasmids
harbor genes for two antigens, Fraction 1 (F1) and LcrV (V) respectively, which are
BDA6G576A@57F:7435F7D;G?7@5AG@F7DE:G?3@4A6KF7?B7D3FGD7A8 R(Kingston et
al. 2007). The F1 antigen has anti-phagocytic functions while V antigen is thought to
function as a key regulator of a Type 3 Secretion System (T3SS) (Kingston et al. 2007).
The T3SS is responsible for injecting Yersinia outer proteins (YopB, YopD, YopO,
YopH, YopM, YopT, YopJ, and YopE) that function to form pores within the wall of a
host immune cell and interfere with immune functions. The Yop proteins can hinder
phagocytosis, stop the release of cytokines, or even induce apoptosis of host immune
cells (Viboud and Bliska 2005). The impairment of the immune system allows for the
proliferation of Y. pestis within lymph nodes, causing severe lymphadenopathy and
eventual septicemia once bacteria reach critical levels in the bloodstream (Prentice and
Rahalison 2007).
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Figure 3. Y. pestis virulence plasmids. Sequencing read coverage indicated in blue, GC
content in green, shown on a relative scale. Red regions designate coding regions and
yellow regions designate mobile elements (Bos et al. 2011).
Other factors promote virulence, including the expression of the yadBC gene,
which encodes an adhesion protein allowing for invasion of epithelial cells in bubonic
plague (Forman et al. 2008). In addition, a plasminogen activator Pla can be expressed,
promoting the fibrinolysis of blood clots and allowing for the bacteria to reside and
multiply uninhibited within the bloodstream (Lathem et al. 2007).
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Disease characteristics of plague. Several types of plague exist, the most
common varieties being bubonic, pneumonic, and septicemic plague (Prentice and
Rahalison 2007). Bubonic plague is distinguished by the presentation of swollen lymph
nodes, or buboes (Figure 4), which accompany high fever, headache, and malaise (Teh
1922). Pneumonic plague is characterized by person-to-person transfer via respiratory
droplets and presents with shortness of breath, chest pain, bloody cough, and high fever
(Ratsitorahina et al. 2000). In addition, septicemic plague can present with symptoms
similar to bubonic plague, but without the appearance of buboes, making it much harder
to diagnose, resulting in high mortality rates (Prentice and Rahalison 2007). Without
treatment before several days of incubation, potentially fatal infections such as
meningitis, pneumonia, and septicemia will occur (Prentice and Rahalison 2007).

Figure 4. Inguinal buboe caused by the rupture of a lymph node (Unknown 1993).

17

V. Molecular Markers and Techniques

Traditional identification of bacteria is performed using microbiological methods,
involving culturing on selective media and observation of various phenotypes and
morphologies. Although well developed, these methods are laborious and can result in
false positives or negatives. Molecular markers rely on the genetic material within the
microorganism for differentiation. A good universal molecular marker is conserved
throughout all organisms, yet provides enough variation to discriminate between
organisms. Several examples of good molecular markers are essential to the organism,
such as RecA and GyrB, or 16S rRNA (Moreno 2005). 16S rRNA genes are likely the
most commonly used molecular marker for prokaryotes to date.

16S rRNA as a molecular marker. The 16S rRNA exist in every prokaryote.
and makes up part of the 30S small subunit of the ribosome, responsible for scaffolding
and structural integrity of the ribosome (Evguenieva-Hackenberg 2005). 16S rRNA genes
are a unique marker because it is completely conserved in all prokaryotes, but has
hypervariable (V) regions that vary between organisms (Figure 5A, B). This allows for
16S rRNA genes to be used as phylogenetic tool to allow for classification of bacteria
and archaea based on the sequence of the 16S rRNA genes (Evguenieva-Hackenberg
2005). The most effective way to target different V regions within the 16S rRNA genes
for sequencing is through PCR amplification with designed primers specific for the
conserved regions.
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Figure 5. 16S rRNA. A) Delineation of hypervariable (V) regions in 16S rDNA. V1-V9
represents the hypervariable regions, linked by conserved orange regions. Base pair sizes
are marked. B) 16S rRNA secondary structure. V1-V9 locations are indicated with sizescaled labels. Modified from Lambert et al. (Lambert et al. 2006)
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Polymerase Chain Reaction (PCR). PCR is capable of exponentially amplifying
billions of copies of a particular gene or DNA sequence of interest by exploiting the
stability changes of double stranded DNA at different temperatures. The PCR requires a
number of components: a template strand of DNA, a polymerase enzyme, ample amount
of nucleotides for polymerization, and short oligonucleotide primers to guide the
amplification process (Mullis 1990; Arnheim and Erlich 1992; Mullis et al. 1992). In
brief, the process involves cycling between temperatures: a high temperature will
denature the dsDNA into ssDNA, a lower temperature will allow primer annealing, and a
slightly higher temperature for strand extension by the polymerase (Figure 6).

Primer design. The primers are largely responsible for the success of a PCR by
binding to particular DNA sequences and directing the reaction. Variation in the design
of the primers dictates the level of specificity of the amplification reaction. The design is
guided by the goal of the experiment, whether it is to amplify DNA from every
microorganism in a community or to amplify a DNA sequence from one species.
The most effective way to designing primers is through the use of bioinformatics
tools. Primer design programs such as Primer3 (Rosen and Skaletsky 1998), sequence
comparison programs such as BLAST (Altschul et al. 1990), or combination programs
such as primerBLAST (Ye et al. 2012) allow for a researcher to design and predict the
specificity of primers. Universal primers are designed to bind to conserved regions and
amplify regions that vary in organisms by using degenerate sequences (Jaric et al. 2013).
This is generally the case for most primers designed to target 16S rDNA for phylogenetic
or

metagenomic

studies

(Wang

and
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Qian

2009).

Alternatively,

primers

Figure 6. Schematic of PCR. The cycling of the denaturation, annealing, and extension
steps results in amplification of the desired product. Exact temperatures for each cycle
depend on the template sequence, the primer sequences, and the optimal working
temperature for the polymerase. (http://www.neb.com)
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designed for amplifying sequences from a specific organism must bind only to DNA
sequences unique to that organism. Species or genus-specific primers are used in many
applications, including the detection of pathogenic agents in the environment. In some
cases these primers can amplify 16S rDNA sequences or gyrB sequences for downstream
sequencing, but chromosomal signature sequences must be found if no sequencing step is
used.

VI. Detection of Biological Warfare Agents

Real time qPCR. The weaponization of biological warfare agents has heightened
the importance of finding quick and sensitive detection assays. Real-time quantitative
PCR (qPCR) assays are a common option for detecting biological warfare agents by
nucleic acid sequence (Thavaselvam and Vijayaraghavan 2010). The two most common
types of qPCR assays are TaqMan and SYBR-Green assays (Life Technologies, Grand
Island, NY). Although based on the same principle of integrating PCR with fluorescence,
TaqMan assay relies on primers and a fluorescent probe that bind to the template, while
SYBR-Green assay utilizes primers and a fluorescent dye that intercalates with dsDNA
(Figure 7).
Regardless of the method used, targeting specific DNA sequences that are unique
can provide a sensitive and specific way to test for the presence that organism (Arikawa
et al. 2008). A number of studies have developed real-time qPCR assays that can identify
important biological warfare agents such as B. anthracis, F. tularensis and Y. pestis
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Figure 7. Comparison of SYBR-Green and TaqMan qPCR assays. (Kim et al. 2013)

(Skottman et al. 2007; Janse et al. 2010). B. anthracis qPCR assays commonly target
pXO1 and pXO2 virulence plasmids (Janse et al. 2010) or species- specific sequences,
such as those in the pag and cap genes (Skottman et al. 2007). Similarly, qPCR assays
designed to detect Y. pestis frequently target sequences in the pla gene (Skottman et al.
2007).
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Microbiological techniques. Other detection methods aside from real-time qPCR
have been developed and will be summarized here. The first and oldest detection method
is performed by observing culture phenotype and morphology and the results of various
biochemical challenges (Thavaselvam and Vijayaraghavan 2010). For example, B.
anthracis can be identified through the following observations: visually matte, flat, white
cultures on nutrient agar, non-hemolytic, non-motile, penicillin sensitive and gamma
phage sensitive with encapsulation observed on nutrient agar with 0.7% bicarbonate
incubated in 5-20% CO2 environment (Turnbull 1999). The disadvantage of culturing is
that live cells are required, and any genetic changes or mutations within the bacterium
could skew the observations and result in misidentification. This is especially poignant in
the case of B. anthracis, which is very hard to distinguish from other B. cereus group
organisms (Ash et al. 1991; Sacchi et al. 2002). Moreover, this method requires time,
specialized equipment, and expertise to be performed properly.

Immunological assays. Another option for detection is using antibody-antigen
assays such as enzyme-linked immunosorbent assay or ELISA (Andreotti et al. 2003;
Thavaselvam and Vijayaraghavan 2010). Immunoassay methods are quite highly
developed for detection of B. anthracis, Y. pestis, Clostridium botulinum, Brucella spp.,
Burkholderia mallei and Burkholderia pseudomallei (Thavaselvam and Vijayaraghavan
2010). The strength and specificity of ELISA assays are directly related to the affinity of
the antibody-antigen interaction. This can be problematic if the affinity is low, because
more substance must to be present as compared to other methods (Thavaselvam and
Vijayaraghavan 2010).
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Emerging technologies. The current trajectory of efforts seems to be towards
speed enhancement and miniaturization for field use without sacrificing specificity and
sensitivity. Miniaturization of nucleic acid detection systems (i.e., qPCR) in cartridges or
glass capillaries are being developed, some already commercially available (Thavaselvam
and Vijayaraghavan 2010). Also on the rise is the use of ‘biosensors’, or a physical
component that is integrated into a biological system to aid in transmission of a
measurable signal. A prime example of biosensor integration is the Autonomous
Pathogen Detection System (APDS) (Lawrence Livermore National Laboratory), which
utilizes Luminex beads, conjugated to specific antibodies for particular biological warfare
agents, to be detected via flow cytometry followed by a secondary PCR confirmatory
assay (Hindson et al. 2005). According to the developers, the system has been proven to
be autonomous and accurate in field-tests performed around the country. Implementation
of such technology could greatly improve public safety without requiring regular
monitoring and testing by laboratories unless necessary.

VII. Surrogate Organisms of Biological Warfare Agents

Surrogates play an important role in research of biological warfare agents and
highly pathogenic organisms. They allow for research to be conducted in laboratories not
properly equipped or certified to experiment with highly virulent organisms (Saikaly et
al. 2007). Ideally, organisms used as surrogates are nearly identical to the target organism
in a variety of parameters such as morphology, genetic similarity, physiology, and
environmental stimuli response (Greenberg et al. 2010). Bacillus thuringiensis and
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Serratia marcescens have previously been used as surrogates for biological warfare
agents B. anthracis and Y. pestis, respectively (Saikaly et al. 2007; Greenberg et al.
2010), and are used in my research.

B. thuringiensis. Bacillus thuringiensis is a Gram-positive spore-forming
bacterium that is found in a variety of environments (Schnepf et al. 1998). B.
thuringiensis is also a member of the B. cereus group of organisms, a phylogenetically
and functionally similar group notoriously difficult to differentiate. Although other
Bacilli spp. such as Bacillus atrophaeus and Bacillus cereus have been used as surrogates
for B. anthracis, research has demonstrated B. thuringiensis closely resembles B.
anthracis with regard to physiology, spore formation, and overall similarity (Greenberg
et al. 2010; Justice 2010).

S. marcescens. S. marcescens is a ubiquitous Gram-negative bacterium
characterized by red-colored colonies (Hejazi and Falkiner 1997). S. marcescens is an
Enterobacteriaceae member that is occasionally implicated in nosocomial infections of
the urinary tract, open wounds, and orbital cavities (Hejazi and Falkiner 1997). Its
phylogenetic similarity to the Yersinia genus has resulted in its usage as a surrogate
organism for Y. pestis for some time (Saikaly et al. 2007). Recently, S. marcescens has
been utilized as a Y. pestis surrogate in studies investigating persistence in environments
such as indoor air circulation systems, building debris leachate, and landfill leachate
(Saikaly et al. 2007; Saikaly et al. 2010).
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VIII. qPCR Identification of Biological Warfare Agent Surrogates

Real-time quantitative PCR (real-time qPCR) is a common method for detecting
biological warfare agents and surrogate organisms. Assays can be designed to target
plasmid-bound sequences, chromosomal sequences, or both (Qi et al. 2001). Plasmidbound sequences are less suited for precise quantification due to variation in plasmid
copy numbers between bacteria of the same species. However, targeting chromosomal
markers allow for more exact quantification due to stability of copy number between
organisms of the same species (Qi et al. 2001). Furthermore, attenuated or altered strains
of pathogenic bacteria can be lacking in one or more of the virulence plasmids, yet still
retain significant pathogenic and infectious capabilities (Ivins et al. 1986; Hadjinicolaou
et al. 2009).
Experimental designs for specific identification of B. thuringiensis have primarily
centered on detection of plasmid-bound cry and cyt genes, which are responsible for
production of parasporal crystals and unique to B. thuringiensis (Porcar and Juarez-Perez
2003). Though chromosomal-bound markers are used for qPCR assays targeting B.
thuringiensis, none provided sufficient distinction of B. thuringiensis from other closely
related B. cereus group organisms (Bavykin et al. 2004). Previous studies have identified
putative species-specific primers targeting the chromosome of S. marcescens in gyrB,
wzm, and recA genes (Saikaly et al. 2007), but the specificity of the primers and probes is
largely untested.

27

IX. Complex Environmental and Clinical Samples

Bacteria do not live in solitude. Environmental and clinical samples are often
complex mixtures, containing a multitude of bacteria, archaea, viruses, and fungi in one
sample. As such, assays used to identify biological warfare agents must be effective when
the target organism is in a complex mixture or matrix. Basic probability and statistical
models have shown that the ‘quality’ of a designed signature sequence varies from
sample to sample, introducing an inherent but unavoidable bias (Reed et al. 2007).
Additionally, elements such as mutation rate, size, and diversity of microbial background
can potentially impose interferences effecting detection of a single species (Reed et al.
2007). Minimal research has been performed on the subject, however one study reports
that increasing concentration of non-target DNA (from Pseudomonas fluorescens) has an
inhibitory effect on amplification of target DNA from E. coli (Ludwig and Schleifer
2000). Moreover, substances that inhibit PCR can be present in environmental or clinical
samples and have an effect on downstream assays (Opel et al. 2010). Although various
extraction protocols can deal with many of these inhibitors, some can persist to disrupt
experiments and skew the outcome.
The biases described above could be negligible in many cases. However, in
instances of low amounts of template DNA concentration or significant interference, this
bias could result in false negative detection. This bias can be evaluated by testing the
specificity and selectivity of an assay designed to detect a single species in isolation
compared to environments with high levels of potential interferences, such as
metagenomic DNA extracted from a microbial community.
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X. Chronic Obstructive Pulmonary Disease Lung Microbiome as a Model System

Chronic obstructive pulmonary disease, or COPD, is a lung disease typified by
emphysema-like destruction of alveoli, airway inflammation, airway fibrosis, and
increased production of mucus (Sethi 2000; Sethi and Murphy 2001; Sethi et al. 2009;
Erb-Downward et al. 2011). COPD can be fatal, responsible for the deaths of
approximately 2.5 million people worldwide in 2000 (Murray et al. 2001). The disease
can be exacerbated by smoking or air pollution, leading to impaired mucocilliary
clearance and weakened immune response (Lopez et al. 2006).
While the microbiome of the COPD lung is still being characterized (ErbDownward et al. 2011), it is clear that a significant exacerbation is correlated with
bacterial infection. The damaged and unnatural environment associated with COPD lungs
has the propensity to promote bacterial colonization. The enhanced growth of bacteria
within the lungs of COPD patients is unique, as a healthy lower respiratory tract is
generally sterile, or colonized by non-pathogenic microorganisms (Sethi 2000; Sethi and
Murphy 2001).
From a forensics standpoint, the COPD lung microbiome is a complex,
heterogeneous community that can be used as testing grounds for detection assays of
biological warfare agents. The lung is the main route-of-entry for important biological
warfare agents such as B. anthracis and Y. pestis, giving real-world significance to the
usage of the COPD lung microbiome DNA as a contaminant. Assay specificity,
sensitivity, and influence of the background can all be effectively tested using a COPD
lung microbiome model.
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XI. Aims

Real-time quantitative polymerase chain reaction (real-time qPCR) has been used
to detect biological warfare (BW) agents such as B. anthracis and Y. pestis in a variety of
environments (Skottman et al. 2007; Janse et al. 2010). However, little is known about
the effect of the immediate environment on the efficacy of the qPCR, particularly if these
bacteria are amongst a complex microbial community, such as bronchoalveolar lavages
(BALs) from the lungs of COPD patients.
In this research, we seek to explore the potential role of the heterogeneous
microbial community DNA on the sensitivity of detecting biological warfare agent using
surrogate organisms of B. anthracis and Y. pestis, B. thuringiensis and S. marcescens,
respectively. The study will be organized into three specific aims:

1. Design species-specific primers targeting B. thuringiensis and S. marcescens
chromosomal signature sequences
2. Test the specificity of the designed primers
3. Examine sensitivity and efficacy of primers when amplifying template DNA in the
presence of DNA from COPD BALs via qPCR

Evaluation of the newly designed primers and amplification between conditions in
a quantitative manner could provide some insight to the practical importance of
background composition on single species detection, particularly in instances of low
template DNA concentration or high amounts of non-target DNA.
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XII. Hypothesis

Real-time qPCR detection of B. thuringiensis and S. marcescens will be
significantly inhibited by the presence of sufficient pulmonary microbiome DNA.
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METHODS

I. In silico Primer Design for B. thuringiensis and S. marcescens

Candidate marker sequences. For B. thuringiensis serovar kurstaki HD-73, the
search for markers began by identifying DNA signatures using the Insignia program
(Figure 8), created by the Center for Bioinformatics and Computational Biology at the
University of Maryland (Phillippy et al. 2009). The open-source program allows for
searching of signature sequences by comparing the genome of the desired organism with
its large database of sequences from many pathogenic bacteria and microorganisms.
Search parameters were set to exclude short sequences and include larger signature
chains (<100 bp), as longer sequences often result in more dissimilarity of a reference
genome to the background.

Insignia
Program

primerBLAST

in silico

in silico

PCR Test

Figure 8. Primer Design Workflow

For S. marcescens strain ATCC 13880T, the exploration for markers began by
obtaining the complete genome sequence of S. marcescens Db11 (Accession #
PRJEB2662, The European Bioinformatics Institute). The sequence is publicly available
in an unannotated shotgun-library format. General areas of interest (such as gyrB) were
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manually located, divided into arbitrary sequence segments, and used as input for the
next step. Previous research has shown gyrB to be more effective in discriminating
between Serratia species than 16S rDNA or other markers (Dauga 2002).

Primer design and analysis. From both search methods, candidate sequences of
large size (300 bp or over) were screened using the NCBI primerBLAST program (Ye et
al. 2012) (Figure 8). The screening process fulfilled several essential functions. It
identifies primer pairs using the Primer3 software while simultaneously testing for
selectivity of the primer on the target genome (≤ 3 base pair mismatches for a 20-mer
primer pair). The primer pairs are automatically input into NCBI BLAST, which
compares the sequences against the GenBank database to produce a list of potential nonspecific binding issues indicative of potential specificity loss. The primer pairs were then
analyzed using the Beacon Designer Free Edition (Premier Biosoft, Palo Alto, CA). The
program calculates and visually presents attributes such as Tm, GC %, probability of selfdimerization, cross dimerization, and hairpin formation, allowing quantitative and
qualitative comparison of candidate primer pairs.

Universal primers. In addition to specific oligonucleotide primers, high
degeneracy universal primers were used as controls (Jaric et al. 2013). The universal
primer pair (designed by Jaric and Narasimhan, BIORG, Florida International University)
used targets 16S ribosomal RNA [rRNA] hypervariable regions of the genome,
specifically the region spanning V6 –V8 regions, which were experimentally determined
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to provide the most coverage and universality (Jaric et al. 2013). The finalized primer
pairs and appropriate information can be found in Table 4.

II. Strains and Culturing

The bacterial strains used in the study are listed in Table 3. The strains were
chosen based on availability and similarity to the two primary strains, B. thuringiensis
serovar kurstaki HD-73 and S. marcescens ATCC 13880T. Bacillus cereus UW85, B.
megaterium ATCC 14581, B. subtilis ATCC 23857 were selected due to their close
relationship with B. thuringiensis, as all are members of the aforementioned B. cereus
group organisms (Bavykin et al. 2004). Additionally, P. aeruginosa PA01, and H.
influenzae ATCC 51907 were selected for their similarity to S. marcescens. Both Gramnegative bacteria commonly found in lungs and are capable of causing infection (Musser
and Beamer 1961; Musher 1983). All strains were grown in standard Luria-Bertani (LB)
Media (Fisher, Pittsburgh, PA) and cultured using aseptic techniques. Cultures for S.
marcescens, B. megaterium, B. cereus, and B. thuringiensis were grown at 30°C while P.
aeruginosa and B. subtilis were grown at 37°C. Sources for strains are noted in Table 4.
Freezer stocks (-80°C) for all strains were maintained in 1:1 LB/glycerol with the
exception of P. aeruginosa, which was maintained in 10% skim milk.
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Table 3. Organisms and strains utilized in the study.
Organism!

Strain I.D.!

Source!

Serratia marcescens!

ATCC 13880!

Lab available!

Bacillus thuringiensis!

HD-73, ATCC 35866!

Purchased from ATCC!

Bacillus megaterium!

ATCC 14851!

Dr. Barry Rosen’s Laboratory!

Bacillus subtilis!

ATCC 23857!

Dr. Barry Rosen’s Laboratory!

Bacillus cereus!

UW85!

Dr. Barry Rosen’s Laboratory!

Pseudomonas aeruginosa!

PAO1!

Lab available!

  
(genomic DNA)!

ATCC 51097!

Lab available!

III. Primer Specificity
Single colonies from both B. thuringiensis and S. marcescens (and all other strains
used) were subjected to phenol/chloroform genomic extraction protocols. Amplification
using all the primers was tested on other closely related bacteria and clinically relevant
bacteria in the strain panel (Table 3) All extracted DNA from all the strains was subjected
to PCR with chosen primers (Table 4), and resulting amplification was visualized on an
agarose gel.

IV. Chromosomal DNA Extraction

The strain of interest was grown overnight in 5 mL of LB broth. To ensure highest
possible yield, a fresh culture was grown to an optical density (OD) of 0.8 for use in the
extraction process. One mL of fresh liquid culture was moved into a 2-mL
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Table 4. Primer sequences used in this study.
Target gene!
B. thuringiensis
hypothetical protein!
B. thuringiensis FAD
- dependent oxidase!
S. marcescens
partial DNA gyrase
B subunit!
S. marcescens
partial DNA gyrase
B subunit!
Universal!
16s rRNA V6-V8!

Accession
number
(position)!

Source!

138!

NZ_CM000751
(2154-2291)!

This study!

194!

NZ_CM000751
(250-444)!

This study!

113!

AJ300536.1
(101-224)!

This study!

138!

AJ300536
(113–251)!

Saikaly et al.,
2007!

320!

N/A!

Jaric et al.,
2013!

Amplicon !
Tm (° C)! %GC!
length (bp)!

Primer!

Primer sequence (5'-3')!

BTK_1F!

GCAAGCAAGGCTGATGGGGCA!

63.4!

61.9!

BTK_1R!

CCACCAGGTGTCGTCTCGGGAT!

63!

63.6!

BTK_2F!

TGGGCAGAAGCAGCAGCGAA!

63.1!

60.0!

BTK_2R!

ACCTCAGCAACAGCACCGCC!

63.7!

65.0!

SM_1F!

CCGCGAAGGCAAAGTGCACGAACA!

64.5!

58.3!

SM_1R!

G(G/C)
CTTGGCCAGAAGCGCACCATAG!

64.5!

62.5!

SM _2F!

AGTGCACGAACAAACTTACAG!

53.4!

42.8!

SM_2R!

GTCGTACTCGAAATCGGTCACA!

56.7!

50.0!

MJ_68F!

TGCATGGWWGTCGTCAGC!

58.6!

61.1!

MJ_68R!

TGTGTACAAGWCCCGWGAACG!

59.4!

57.1!

microcentrifuge tube and centrifuged for 5 minutes at 13,300 rpm. The supernatan
removed and the pellet was resuspended in 0.5 mL Bacterial Lysis Buffer B1 (50
-F=GP@D!  A&- D!  -K99B  -F=HCB-X100, Qiagen)
K5G:C@@CK986MH<9588=H=CBC:µ%+'5G9 µL of lysozyme (100 mg/mL) a
µ% )FCH9=B5G9 $   A; A% H<9B =B7I65H98 5H O :CF   A=BIH9G  -<9B 
57H9F=5@ %MG=G I::9F   & ;I5B=8=B9 <M8FC7<@CF=89   -K99B   *=5;9B 
58898HCH<9G5AD@9A=L986M=BJ9FG=CB5B8=B7I65H985H O:CF5BCH<9F A=Bu
-C 9LHF57H H<9 657H9F=5@ ' 5B 9EI5@ JC@IA9 C: D<9BC@-chloroform so
 µL) was added to the lysed bacteria and vortexed for 10 seconds. The tub
centrifuged for 15 minutes at 13,300 rpm to fully separate the biphasic mixtur
=GC@5H9 H<9 BI7@9=7 57=8G :FCA DFCH9=B 9LHF5B9CIG +' 5B8 @=D=8 AC@9
,I6G9EI9BH@MH<95EI9CIGD<5G9HCD@5M9F7CBH5=B=B;H<e nucleic acids was trans
HC5B9K-A%A=7FC79BHF=:I;9HI69 -CDF97=D=H5H9H<9'

th

of the volum

& GC8=IA 579H5H9 'O7, !3OONa) was added, followed by an addition o
volumes of ice-cold ethanol. The tube was vortexed thoroughly and placed in
overnight.
The tube was centrifuged for 5 minutes at 13,300 rpm. The supernatan
8=G75F898H<9D9@@9HK5GK5G<98K=H< 9H<anol, and then fully dried using a vac
79BHF=:I;9 -<9D9@@9H7CBH5=B=B;'K5GGI6G9EI9BH@MF9GIGD9B898=B µL of 1
-F=G9@IH=CB6I::9F5B8GHCF985HOCF- O:CF8CKBGHF95AIG9 -<9'
EI5BH=:=98 J=5 ./ GD97HFCD<CHCA9HFM CB H<9 =C-9? ,MB9F;M !- &I@H=-9H
&=7FCD@5H9+9589F0=BCCG?=/-5B85-5?9A=7FCD@5H9=C-9?0=BCCG?=/-
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V. Species-Specific PCR Amplification of B. thuringiensis and S. marcescens

 G=B;@9 )+ K5G 89G=;B98 5B8 CDH=A=N98 HC 5AD@=:M ;9BCA=7 ' from B.
thuringiensis or S. marcescens using the putative species-specific primers in Table 4 G
GI7< H<9 )+ F957H=CB 5@GC G9FJ98 HC H9GH :CF BCB-specific amplification against g'
from all other available strains (Table 4). Final concentrations and volumes of the
F957H=CBA=LHIF95F95G:C@@CKGµ%C:
µL of 10 µ& 8'-)G

1)+I::9F A&&;@) (Qiagen), 0.4

 µL of forward and reverse primers (10 µ&

 µL

!CH,H5F-5EPlus (Qiagen), 1 µL of 10 ng/µL 'H9AD@5H95B8 µ%C:)+ water.
@@ 5AD@=:=75H=CBG K9F9 D9F:CFA98 CB 9=H<9F 5 &# +9G95F7< )--

 )9@H=9F

-<9FA5@ M7@9F &# +9G95F7< 05@H<5A & CF 5 -97<B9 -CI7<;9B9 F58=9BH )+
-<9FA5@ M7@9F -97<B9 IF@=B;HCB '#  -<9 5AD@=:=75H=CB D5F5A9H9FG IG98 K9F9 5G
:C@@CKGO:CFA=BIH9G=B=H=5@89B5HIF5H=CB5B8!CH,H5F-5EPlus activation, followed
6M   7M7@9G C: 89B5HIF5H=CB 5H O :CF   G97CB8G DF=A9F 5BB95@=B; 5H  O :CF  
G97CB8G5B89LH9BG=CB5HO:CF A=BIH9:C@@CK986M5:=B5@9@CB;5H=CBGH9D5HO
for 10 minutes '9;5H=J97CBHFC@GK9F9D9F:CFA98K=H<CIH588=H=CBC:H9AD@5H9'HC
observe possible contamination. Positive control amplification of P. aeruginosa wit< ,
universal primers (Table 4) was used to confirm amplification success.

VI. Agarose Gel Electrophoresis

  CF  K9=;<H JC@IA9 5;5FCG9 9@97HFCD<CF9G=G ;9@ &

 ,7=9BH=:=7 # -

Baker® ;5FCG9 ,H5B85F8 %CK @97HFC9B8CGACG=G )@95G5BH )F5=F=9 0" K5G FIB HC



89H9FA=B9H<95AD@=:=75H=CB9::=757MC:H<9)+F957H=CB @97HFCD<CF9G=GK5G75FF=98out
in 0.5X Tris-Borate---6I::9F &-F=G-CF5H9

&-D!  

100-6D ' @5889F K5G @C5898 5G G=N9 F9:9F9B79 CB 5@@ ;9@G )FCA9;5 &58=GCB 0" 
9@G K9F9 GH5=B98 K=H< "BJ=HFC;9B ,2+Q ,5:9 ' 9@ ,H5=B %=:9 -97<BC@C;=9G
F5B8 "G@5B8 '2 5B8 J=9K98 5B8 D<CHC;F5D<98 IB89F ./ HF5BG-illumination on a
$($ 9@%C;=7

"A5;=B;,MGH9A5F9GHF95A!95@H<+C7<9GH9F'2

VII. Bronchoalveolar Lavage (BAL) DNA Samples

-CH5@ ' K5G =GC@5H98 :FCA 6FCB7<C5@J9C@5F @5J5;9 % G5AD@9G from five
GI6>97HG7C@@97H98IB89FH<9"+5DDFCJ98DFCHC7C@ 

-

)FCHC7C@ 

-01 is

57C@@56CF5H=J9DFC>97HK=H<F 85A05BB9F5B87C@@95;I9G5HH<9.B=J9FG=HMC:&=5A=
.& @@GI6>97H=BH9F57H=CBF97FI=HA9BH7CBG9BH%G5AD@=B;K5GD9rformed at the
.& G=H9  ,5AD@9G :CF H<=G DFC>97H K9F9 GD5F9 G5AD@9G H<5H KCI@8 CH<9FK=G9 <5J9 699B
discarded, providing no barrier to the completion of the aforementiCB98 DFC>97H  %
samples from five subjects were selected for this project.

BAL DNA extraction. -CH5@ A9H5;9BCA=7 ' :FCA % G5AD@9G K5G
9LHF57H98 IG=B; 5 5GH' ,)"' $=H :CF ,C=@ &) =CA98=75@G ,C@CB (! 5B8 5
AC8=:=98 J9FG=CB C: H<9 7CAD@9A9BH5FM DFCHC7C@  =FGH  µ@ C: % G5AD@9 K5G
HF5BG:9FF98 HC 5 %MG=B; &5HF=L  HI69 5B8  µ@ &- I::9F  -

 !O, 1-

10!14NNaO · !O, 1- '5 !SO4, 1- !9NO)n   )FCDF=9H5FM
=BCF;5B=7 G5@HG &) =CA98=75@G K5G 58898  ": H<9 G5AD@9 <58 @9GG H<5B  µl, the
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remaining volume was supplemented with sodium phosphate buffer (90-

 !O, 1-

 '5!PO4) provided in the kit. The sample was homogenized in the FastPrep
=BGHFIA9BH:CF G97CB8G5H5GD998G9HH=B;C: H<9B79BHF=:I;985H 

FDA:CF



minutes to pellet the cellular debris. The supernatant was transferred to a 7@95B -mL
micFC79BHF=:I;9 HI69 H<9B   µl protein precipitation sC@IH=CB  -  !O, 30- 
'5(7 -!4O&)=CA98=75@GK5G588985B8A=L986MG<5?=B;H<9HI69



times. The sample was centrifuged again at 13,300 rpm for five minutes to pellet the
protein precipitate. The supernatant was transferred to a clean 15-mL polypropylene tube.
-C =GC@5H9 H<9 '  A% C: F9GIGD9B898 =B8=B; &5HF=L GIGD9BG=CB GC@IH=CB
 -  !N4S, 10- !O, 10- &),=@=75&)=CA98=75@GK5G58898HCH<9
GID9FB5H5BH -C5@@CKGI::=7=9BH6=B8=B;C:'HCH<9G=@=75A5HF=LH<9HI69K5GD@5798
on a rotator at slow-medium speed for two minutes and the tube was placed in a rack for
three additional minutes. The mixture was then re-suspended 5B8
,)"' =@H9F5B85H7<-I695DD5F5HIG5B879BHF=:I;985H 

µl was added to a

FDA:CFCB9A=BIH9 -<9

7CBH9BHG C: H<9 75H7< HI69 K9F9 8=G75F898 H<=G 7M7@9 C: 588=B; A=LHIF9 =B 

 µl

increments, centrifuging, and emptying the catch tube continued until all of the mixture
has been passed through the filter.
 

 µ@ 5@=EICH C: DF9D5F98 ,5@H H<5BC@ 05G< ,C@IH=CB ,0,-&  - 

!O, 10- -F=G-!@&)=CA98=75@GK5G588985B8H<9D9@@9H56CJ9H<9,)"' filter
was gently re-GIGD9B898 IG=B; H<9 :CF79 C: H<9 @=EIid from the pipet tip. The tube was
centrifuged from one minute at 13,300 rpm and the catch tube was emptied. To ensure
complete ‘drying’ of the matrix of residual wash solution, the tube was centrifuged again
:CFHKCA=BIH9G5H 

FDA !CK9J9FBCKH<e catch tube is discarded and replaced
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with a B9K 7@95B 75H7< HI69  -<9 ,)"' :ilter was air-dried for 5 minutes at room
H9AD9F5HIF9H<9' =B8=B;A5HF=LA=LHIF956CJ9H<9,)"':ilter was re-suspended in
100 µ@C:,'5G9 )MFC;9B-F9905H9F -C=B7Fease yield and elution efficiency of
':FCAH<9=B8=B;A5HF=LH<9HI69K5G=B7I65H98:CF:=J9A=BIH9G5HT=B<95H
block or water bath.
-<9HI69K5G79BHF=:I;985H 

FDA:CFCB9A=BIH9HC6F=B;9@IH98'=BHC

the clean catch tube. The resultiB; ' K5G F958M :CF )+ 5B8 CH<9F 8CKBGHF95A
applications and stored at - T :CF 9LH9B898 D9F=C8G CF T :CF G<CFH9F D9F=C8G  -<9
' K5G EI5BH=:=98 J=5 ./ GD97HFCD<CHCA9HFM CB H<9 =C-9? ,MB9F;M !- &I@H=9H97H=CB&=7FCD@5H9+9589F0=BCCG?=/-

VIII. Real-time qPCR Sensitivity Experiments

The sensitivity and specificity of the primers were tested using pure template
' 5B8 ' GD=?98 with metagenomic ' 9LHF57H98 :FCA :=J9 % G5AD@9G  @@
E)+9LD9F=A9BHGwere performed using the DD@=98Biosystems 7500 Real--=A9)+
,MGH9A&58=GCB0" +957H=CBA=LHIF9G:CF957< µl volume contained 7 µ@&=@@=*
!O, 10 µ@ L ,2+Q F99B )+ &5GH9F &=L  µ@ H9AD@5H9 '  µl of 10 B&
forward primer, and 1 µl of 10 B&F9J9FG9DF=A9F The cycling param9H9FGK9F9 T:CF
A=BIH9GT:CF G97CB8G=B=H=5@89B5HIF5H=CB 7M7@9GC:89B5HIF5H=CB5HT
:CF G97CB8G5B8DF=A9F5BB95@=B; 9LH9BG=CB5HT:CF A=BIH9T:CF A=BIH9 
Fluorescence data was automatically collected after each amplification cycle.
88=H=CB5@@M 5 A9@H 7IFJ9 5B5@MG=G K5G D9F:CFA98 =AA98=5H9@M :C@@CK=B; H<9
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5AD@=:=75H=CB69;=BB=B;5H T=B7F95G=B;6M T=B7F9A9BHG9J9FM G97CB8GIBH=@
T @ICF9G79B7985H5K5G7C@@97H985H9J9FMH9AD9F5HIF9=B7F9A9BH=Bcrease.

B. thuringiensis gDNA spiking experiments. -<9t values were determined for
amplification of three concentrations of B. thuringiensis  



 B; U% C:

;9BCA=7';'K=H<H<9-$1_+DF=A9FD5=FK<9B%'9LHF57HG%
1-K9F958898 %'7CB79BHF5H=CBK5GBCFA5@=N98GCH<5H5DDFCL=A5H9@M

B;

K5GDF9G9BH=B957<G5AD@9 @@9LD9F=A9BHGK9F9FIB=BHF=D@=75H9G GH5B85F87IFJ9K5G
produced using 1:5 dilutions of B. thuringiensis ;'   



 5B8



B; U%7CB79BHF5H=CBG @@FIBG=B7@I898B9;5H=J97CBHFC@G

S. marcescens gDNA spiking experiments. ,=A=@5F@Mt values were determined
for amplification of three concentrations of S. marcescens  



 B; U%

;'K=H<H<9,&1_+DF=A9FD5=FK<9B%'9LHF57HG% -5) were added.
% ' 7CB79BHF5H=CB K5G BCFA5@=N98 GC H<5H 5DDFCL=A5H9@M 

 B; K5G DF9G9BH =B

957< G5AD@9  @@ 9LD9F=A9BHG K9F9 FIB =B HF=D@=75H9G   GH5B85F8 7IFJ9 K5G DFC8I798
using 1:5 dilutions of S. marcescens ;'   



 5B8

 B; U%  @@

runs included negative controls.

IX. Data Analysis

@@85H5were 5B5@MN98IG=B;6CH<
programming scripts. The R scripts used 



,C:HK5F9J 

5B8+- language

,C:HK5F9F5K85H5CIHDIH5G=BDIH85H5

HC J=GI5@=N9 F9GI@HG IG=B; 6CLD@CHG 5B8 H9GH :CF G=;B=:=75B79 IG=B; B5@MG=G C: /5F=5B79
'(/5B8DCGH<C7-I?9M!CB9GH@M-,=;B=:=75BH=::9F9B79!,H9GHG H9AD@5H9
R script was constructed to facilitate easy manipulation for each data set (Figure 9).
Results from all assays were compared to determine any significant differences in
performance with different backgrounds (mispriming, non-specific amplification, or
concentration dependent effects).

Figure 9. Sample R-language Script. () indicates commentary, not executable script.
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RESULTS

I. Primer Design

For species-GD97=:=7 )+ 5AD@=:=75H=CB C: B. thuringiensis and S. marcescens,
primers were either designed using the workflows described in the methods or identified
in existing literature (Table 4).
)+K5GD9F:CFA98HC9J5@I5H9H<956=@=HMC:H<9DF=A9FD5=FGHC5AD@=:MH<9=F
=BH9B898 H5F;9HG   H9AD@5H9 A=LHIF9 C:  B; C: ;' :FCA S. marcescens, B.
megaterium, B. cereus, and B. thuringiensis, B. subtilis was created as the template for all
F957H=CBG @97HFCD<CF9G=GIG=B;55;5FCG9;9@K5GFIBHCJ=GI5@=N9H<9amplification
products (Figure 10).
Serratia marcescens ' K5G GI779GG:I@@M 5AD@=:=98 IG=B; 6CH< H<9 ,& 4+
5B8 ,&4+ Drimer pairs, as evidenced by the single product bands at the expected
5AD@=7CB G=N9G

 6D 5B8  6D, respectively (Figure 10 %5B9     Bacillus

thuringiensis 'K5G5@GC9::97H=J9@M5AD@=:=98IG=B;-$ 4+5B8-$4+DF=A9F
pairs, indicated by H<9A5>CFDFC8I7H65B8G5H 6D5B8  bp, respectively (Figure 10,
%5B9     G 9LD97H98 H<9 , &#4+ DF=A9FG 5AD@=:=98 B. thuringiensis very
successfully as indicated by the major DFC8I7H65B85H 6D=;IF9

%5B9 'C-

template control 7CBH5=B=B; &#4+ DFC8I798 BC 5AD@=:=75H=Cn products (Figure 10,
Lane 7). No primer dimers were formed, as evidenced by the lack of any bands in the 3050 bp range.
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Figure 10. 9@9@97HFCD<CF9G=GC: )+DFC8I7HGfor each primer pair (Table 4). Template
K5G 5 A=LHIF9 C:  B; U% C: ;' 9LHF57H98 :FCA 957< D5B9@ A9A69F  -<9 '
mixture was amplified using the respective species-specific primers (Table 4) and run on
5  - 5;5FCG9 9@97HFCD<CF9G=G ;9@  %5B9 
 6D @5889F %5B9  S. marcescens
5AD@=:=75H=CBK=H<,& 4+DF=A9FG%5B9S. marcescens 5AD@=:=75H=CBK=H<,&4+
primers, Lane 4: B. thuringiensis amplification with BTK1_FR primers, Lane 5: B.
thuringiensis 5AD@=:=75H=CBK=H<-$4+DF=A9FG%5B9&=L98;'5AD@=:=75H=CB
K=H< , &#4+ DF=A9FG %5B9  &#4+ DF=A9FG K=H< BC H9AD@5H9 '
(- control).
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II. Primer Specificity

-<9-$ 4+-$4+,& 4+5B8,&4+DF=A9FD5=rs were tested for
GD97=:=7=HM5;5=BGH5GA5@@D5B9@C:GHF5=BG-56@9 @@GHF5=BGK9F9GI6>97H98HC)+
5AD@=:=75H=CB K=H< 957< DF=A9F D5=F =B7@I8=B; , DF=A9F D5=F &#4+ (Figure 11).
-<9DFC8I7HGK9F9FIBCB5-5;5FCG9;9@K=H<5

-bp ladder for size reference,

5B8GI6G9EI9BH@MJ=9K98IB89F./HF5BG-illumination.
-<9 -$ 4+ 5B8 -$4+ DF=A9F D5=FG 6CH< DF9:9F9BH=5@@M 5AD@=:=98 B.
thuringiensis5GBCH986MG=B;@9DFC8I7H65B8G5HH<9DF98=7H985AD@=7CBG=N9GC: 6D
and 194 bp respectively (Figure 11%5B9G  &CF9CJ9F-$ 4+BCF-$4+
DF=A9F D5=FG DFC8I798 5BM 5AD@=:=75H=CB C: ' :FCA B. cereus, B. megaterium, B.
subtilis, S. marcescens, P. aeruginosa, or H. influenzae (Figure 11, Lanes 17- -30).
,=A=@5F@M H<9 ,& 4+ 5B8 ,&4+ DF=A9F D5=FG 5@GC 5AD@=:=98 S. marcescens
preferentially. Single product bands are clearly distinguishable at predicted amplicon
G=N9GC:

6D5B8 6D:CF,& 4+5B8,&4+DF=A9r pairs, respectively (Figure

11%5B9G 'C5AD@=:=75H=CBC:':FCAB. cereus, B. megaterium, B. subtilis, S.
marcescens, P. aeruginosa, or H. influenzae K5G C6G9FJ98 K=H< ,& 4+ CF ,&4+
primer pairs (Figure 11, Lanes 3-

- 

88=H=CB5@@M H<9 DCG=H=J9 7CBHFC@ DF=A9F D5=F  , &#4+ GI779GG:I@@M
amplified ' :FCA 5@@ GHF5=BG =;IF9

, Lanes 33-39), indicating that the extracted

' :FCA 957< D5B9@ A9A69F K5G 5AD@=:=56@9. The negative no-template controls
'-:CF957<DF=A9FD5=FDFC8I798BCA95surable amplification (Figure 11, Lanes 4145)
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Figure 11. 9H9FA=B5H=CBC:DF=A9FGD97=:=7=HM B. thuringiensis (-$ 4+-$4FR)
and S. marcescens ,& 4+ ,&4FR) primer pair specificity is tested against related
and common lung microbes (Table 3  )+ products were visualized using gel
9@97HFCD<CF9G=G-5;5FCG9;9@ AD@=:=75H=CBK=H<H<9IB=J9FG5@DF=A9FD5=F ,
&#4+K5GIG985GDCG=H=J97CBHFC@
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III. Comparison of B. thuringiensis-specific Primers

Previous results demonstrated that B. thuringiensis ' 75B 69 successfully
amplified IG=B; H<9 -$ 4+ CF -$4+ DF=A9F pairs (Figure 10  !CK9J9F H<9
amplification with BTK1_FR (Figure 10, Lane 4) produces a thicker band as compared to
-$4+=;IF9

%5B9 "B588=H=CBHCH<9 -bp amplicon, the amplification with

-$4+DFC8I798:5=BH65B8G5H 6D5B8

6D (Figure 10, Lane 5).

CF5DF97=G97CAD5F=GCBC:H<9-$ 4+5B8-$4+DF=A9FD5=FGHF=D@=75H9
,2+-;F99BE)+5GG5MGK9F9D9F:CFA98IG=B;HKC8=::9F9BH7CBcentrations of template
' 

5B8  B; U% =;IF9 )  &95B t values were determined at the point of

intersection with the H<F9G<C@8J5@I9@=B9=;IF9 ) and reported in Table 5, along with
H<F9G<C@8J5@I9 H

ng of B. thuringiensis '5GH<9H9AD@5H9H<9amplification with

-$ 4+ DF=A9FG t    -56@9  7rossed threshold approximately five cycles
69:CF9H<95AD@=:=75H=CBK=H<-$4+DF=A9FGt  -56@9 

Table 5. CAD5F=GCBC:-$ 4+5B8-$4+DF=A9FG 
Primers!

Tm(°C)!

BTK1_FR!

77.69!

BTK2_FR!
!

77.5 !

Template !
(ng/μL)!

Mean Ct
Value!

10!

27.683!

1!

31.033!

10!

32.494!

1!

36.64!

Threshold
(ΔRn)!
.2!
.2!

Melt Curve
Peak Height!
(-Rn)!
2.9-3!
2.5-2.6!
1.6-1.8!
0.7-0.9!

* t values were calculated from amplification data, threshold values were set at 0 5B8
Tm and peak heights were determined via software calculation and melt curve (Figure
13).
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Figure 12. ,9BG=H=J=HM C: H<9 -$ 4+ 5B8 -$4+ DF=A9F pairs. Two different
amounts (1 or 10 ng) of purified B. thuringiensis ;' K9F9 IG98 5G H<9 H9AD@5H9 :CF
5AD@=:=75H=CB  t values were determined as the intercept of the magnitude of the
fluorescence signal (ΔRn) with the calculated threshold line (Table 5). The reported mean
t values for a given sample are from triplicate runs.
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.G=B; 5 GA5@@9F 5ACIBH C: B. thuringiensis ' 5G H9AD@5H9 

B; U% yielded

comparable results, with the amplification with BTK1_FR primers t = 31.03) (Table 5)
reaching threshold over five cycles before the amplification with -$4+ primers t =
 ) (Table 5). H 6CH< 7CB79BHF5H=CBG H<9 8=::9F9B79G =B t values were found to be
statistically significant via one-tail t-test (p < .05).
Post-amplification melt curve analyses were performed for both BTK1_FR and
-$4+ DF=A9F pairs (Figure 13) with 10 5B8  B; U% B. thuringiensis g' The
analysis determined Tm values and peak heights (Table 5) for each condition,
representative of the temperature of amplicon dissociation and amount of fluorescence
lost as a result. The Tm for BTK1_FR 5B8-$4+ amplification products were similar,
  T and  T, respectively (Table 5). Only single peaks associated with the Tm
K9F9 C6G9FJ98 =B8=75H=B; H<9 DFC8I7H=CB C: 5 G=B;@9 )+ DFC8I7H H 5 <=;<9F
concentration of B. thuringiensis ' 

 B; U% A9@H 7IFJ9 D95? <9=;<HG :CF

BTK1_FR amplification products (Figure 13) are approximately two times higher than
that of H<9-$4FR (Table 5). The difference in peak heights is increased for the lower
B. thuringiensis '7CB79BHF5H=CB B; U%=;IF9 ), with observed heights nearly
three H=A9G<=;<9F:CFH<9-$ 4+H<5BH<9-$4+5AD@=:=75H=CB (Table 5).

IV. Comparison of S. marcescens-specific Primers

-<99::97H=J9B9GGC:,& 4+5B8,&4+DF=A9FD5=FG-56@95AD@=:M=B;S.
marcescens ;'K5G7CAD5F98K=H<)+ 5;5FCG9;9@K5GFIBHCJ=GI5@=N9H<9
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BTK2_FR((10(ng)(
BTK2_FR((1(ng)(

Derivative Reporter (-Rn)

2.5

2.0

1.5
5

1.0
0

0.5
5

65

70

75

80

85

90

95

Temperature °C
Figure 13. &9@H-curve 5B5@MG=G IG=B; -$ 4+ 5B8 -$4+ DF=A9F D5=FG B.
thuringiensis species-specific primers -$ 4+5B8-$4+ amplified two different
amounts of B. thuringiensis ;' (1 or 10 ng). The negative value of the change in rate
of fluorescence (-Rn’) is plotted against temperature. The curves from three replicates
from each primer pair and template concentration are shown.
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amplification products (Figure 9\10). Previous results in this study have shown that S.
marcescens g' is successfully 5AD@=:=98 IG=B; H<9 ,& 4+ 5B8 ,&4+ DF=A9F
pairs (Figure 10 %5B9 -3), although amplification with ,& 4+ DFC8I79G 5 G@=;<H@M
89BG9F65B8 CF6CH<,& 4+5B8,&4+ primer pairs, only the expected amplicons
5F9DF9G9BH

5B8 F9GD97H=J9@M (Figure 10%5B9-3Figure 11%5B9

CF 5 ACF9 577IF5H9 7CAD5F=GCB C: H<9 ,& 4+ 5B8 ,&4+ DF=A9F D5=FG
HF=D@=75H9 ,2+-;F99B E)+ 5GG5MG K9F9 D9F:CFA98 IG=B; HKC 8=::9F9BH 7CB79BHF5H=CBs
C:H9AD@5H9'

5B8 B; U% (Figure 14) &95Bt values were determined at the

point of intersection with the calculated threshold value line (Figure 14-56@9 .G=B;
10 B; U% of S. marcescens '5GH<9H9AD@5H9amplification using the ,& 4+t =
 ) 5B8,&4+DF=A9FG t   ) -56@9F957<98H<F9G<C@85HH<9G5A97M7@9
(Figure 14).
Table 6. CAD5F=GCBC:,& 4+5B8,&4+DF=A9FG 
Primers!

Tm (°C)!

SM1_FR!

86.33 !

SM2_FR!
!

86.52 !

Template !
(ng/μL)!

Mean Ct
Value!

10!

16.66!

1!

20.294!

10!

16.66!

1!

20.096!

Threshold
(ΔRn)!
.2!
.2!

Melt Curve
Peak Height!
(-Rn)!
3.2!
3-3.1!
2.8-3!
3-3.1!

* t J5@I9G K9F9 75@7I@5H98 :FCA 5AD@=:=75H=CB 85H5 H<9  GC:HK5F9 5IHCA5H=75@@M
calculated threshold values, and Tm and peak heights were determined via the melt curve
(Figure 15).
 smaller amount of S. marcescens g' 5G H9AD@5H9 

B; U% yielded

comparable results, with the amplification using ,& 4+ t   ) 5B8 ,&4+
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Figure 14. ,9BG=H=J=HMC:H<9,& 4+5B8,&4+DF=A9FD5=FG -KC8=::9F9BH5ACIBHG
(1 or 10 ng) of purified S. marcescens ;'K9F9IG985GH<9H9AD@5H9:CF5AD@=:=75H=CB 
t values were determined as the intercept of the magnitude of the fluorescence signal
(Δ+B K=H< H<9 75@7I@5H98 H<F9G<C@8 @=B9 -56@9   -<9 F9DCFH98 A95B t values for a
given sample are from triplicate runs.
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DF=A9FG t  

) -56@9  F957<=B; H<F9G<C@8 5H 5DDFCL=A5H9@M H<9 G5A9 7M7@9 H

6CH<7CB79BHF5H=CBGH<98=::9F9B79G=Bt values are not significant (p < .05).
Post-5AD@=:=75H=CB A9@H 7IFJ9 5B5@MG9G K9F9 D9F:CFA98 :CF 6CH< ,& 4+ 5B8
,&4+DF=A9Fpairs (Figure 15) with 10 5B8 B; U%S. marcescens ' Tm values
5B8 D95? <9=;<HG 5F9 F9DCFH98 =B -56@9   -<9 Tm value for ,& 4+ 5B8 ,&4+
amplification products were  T and  T, respectively -56@9 Similar results
were observed at a higher concentration of S. marcescens ' 

 B; U%. The

similarity in peak heights is conserved for the lower S. marcescens '7CB79BHF5H=CB 
B; U% =gure 15), with observed heights nearly identical for both the primer pairs
-56@9   !CK9J9F IB8I@5H=CBG =B H<9 7IFJ9 5H @CK9F H9AD9F5HIF9 H<5B H<9 -m are
C6G9FJ98 =B ,&4+ 5AD@=:=75H=CB C: 6CH< H9AD@5H9 7CB79BHF5H=CBG Figure 14). The
presence of a small shoulder peak at a Tm C:5DDFCL=A5H9@M T suggests the presence of
a small amount of an additional second product (Figure 15). The second product is not
observed in H<9,& 4+A9@H7IFJ9=;IF9 ).

V. B. thuringiensis qPCR Assay Using BTK1_FR Primers
To inv9GH=;5H9 H<9 9::97H C: A9H5;9BCA=7 ' CB amplification of B.
thuringiensis '5,2+-;F99BE)+5GG5MK5GD9F:CFA98IG=B;H<9GD=?=B;G7<9A9
CIH@=B98 =B H<9 A9H<C8G  "B 6F=9: H<9 -$ 4+ DF=A9F D5=F K5G IG98 HC 89H97H B.
thuringiensis ' C: J5FM=B; 7CB79BHF5H=CBG K<9B GD=?98 K=H< 

 B; C: BCB-target

' :FCA :=J9 % ' 9LHF57HG  )IF=:=98 B. thuringiensis ;' K9F9 IG98 HC
construct 75@=6F5H=CB7IFJ9G=;IF9 HC5GG9GGH<9EI5@=HMC:H<9'.
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Figure 15. &9@H-IFJ95B5@MG=G:CF,& 4+5B8,&4+DF=A9FD5=FG S. marcescens
species-specific ,& 4+5B8,&4+primer pairs amplified two different amounts (1
or 10 ng) of S. marcescens ;'  -<9 B9;5H=J9 J5@I9 C: H<9 change in rate of
fluorescence (-Rn’) is plotted against temperature. The curves from three replicates from
each primer pair and template concentration are shown.
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Figure 16. 5@=6F5H=CB 7IFJ9 for B. thuringiensis ' 5AD@=:=75H=CB with BTK1_FR
primers. LC;C:H<9GH5FH=B;EI5BH=H=9Gis plotted against the A95Bt values of BTK1_FR
amplification of purified B. thuringiensis ;'  -<9 6@I9 GMA6C@G F9DF9G9BH H<9
HF=D@=75H9)+5AD@=:=75H=CBC:H<9GH5B85F8'G5AD@9G 0 0.04, 0  and 0 
B; U%7CB79BHF5H=CBG %=B95FF9;F9GG=CB5B5@MG=GM=9@898H<9F9DCFH98G@CD95B8+ value.
The t values varied with H<9 5ACIBH C: H9AD@5H9 ' in a dose-dependent
manner. I9HC H<97CAD@9LB5HIF9C:H<9E)+5GG5M=HK5G89H9FA=B98H<5H5box plot
analysis (accompanied by appropriate statistical testing) for each concentration would
represent the data most effectively (Figure 17). .DCB J=GI5@ =BGD97H=CB H<9 @CK9F
template conc9BHF5H=CB=;IF9 )5B9@) has a <=;<9FA95Bt values compared to the
higher template concentration (Figure 17, Panel B), which is an expected dose-dependent
effect &CF9=BH9F9GH=B;@M in four out of five 75G9G'GD=?98K=H< %'K=H<
H<9 9L79DH=CB C: %  <58 8=::9F9BH A95B t values as compared to the unspiked
;' -C89H9FA=B9=:H<9G98=::9F9B79G5F9G=;B=:=75BHGH5H=GH=75@H9GHGK9F9D9F:CFA98
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Figure 17. Box plot of Ct values for spiked and unspiked B. thuringiensis DNA. Ct values were determined for amplification
of two amounts of B. thuringiensis (A) 0.2 ng and (B) 0.04 ng of genomic DNA unspiked (US) spiked with BAL DNA (BAL
1-5) using the BTK_1FR primer pair. Approximately 200 ng of DNA is present in each BAL sample. amplifications with
0.008 ng of template failed to reach threshold and were excluded. * Significantly different from 0.2 ng control (p < 0.05), **
Significantly different from the 0.04 ng control (p < 0.05).
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A one-way ANOVA was conducted to compare Ct values of the unspiked control
(0.2 ng B. thuringiensis DNA) and the spiked samples (0.2 ng B. thuringiensis gDNA +
BAL DNA) using the BTK1_FR primers. A significant effect on the mean Ct values was
seen between almost all samples (p < .05). A Post-hoc Tukey HSD test indicated that the
mean Ct value of the unspiked 0.2 ng control (32.01 ± 0.32) was significantly lower than
the mean Ct value of samples spiked with DNA from BAL 1 (34.98 ± 0.21, p-value = 1.7
x 10-6), BAL 3 (34.02 ± 0.64, p-value = .0001), BAL 4 (33.45 ± 0.17, p-value = 0.0021),
and BAL 5 (35.81 ± .19, p-value = 1x10-7). No significant difference was observed
between the mean Ct values of the 0.2 ng control (32.01 ± 0.32) and the BAL 2 spiked
sample (31.45 ± 0.24, p-value = 0.386).
Similarly, a one-way ANOVA was conducted to compare mean Ct values of the
unspiked control (0.04 ng B. thuringiensis gDNA) and the spiked samples (0.04 ng B.
thuringiensis gDNA + BAL DNA). A significant effect on the mean Ct values was seen
between most samples (p < 0.05). A Post-hoc Tukey HSD test indicated that the mean Ct
value of the 0.04 ng control (34.48 ± 0.43) was significantly lower when unspiked as
compared to samples spiked with BAL 1 (38.02 ± 0.14, p-value = 7.2 x 10-6), BAL 3
(36.61 ± 0.44, p-value = 0.00071), BAL 4 (37.64 ± 0.68, p-value = 6.21 x 10-5), and BAL
5 (38.55 ± .35, p=1.8x10-6) samples. However, no significant difference was observed
between the mean Ct values of the 0.04 ng control (34.48 ± 0.43) and the BAL 2 spiked
sample (34.16 ± .56, p-value = 0.9859).
A melt curve analysis was performed post amplification (Figure 18). The curve
indicates the major amplicon disassociation of all samples to be at Tm  C Some
lingering fluorescence occurs after the main amplicon dissociation Tm (Figure 18).
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Figure 18. Melt-Curve analysis using BTK1_FR primers and spiked B. thuringiensis
DNA. The normalized reporter fluorescence (Rn) values are plotted against temperature.
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VI. S. marcescens qPCR Assay Using SM1_FR Primers
To investigate the effect of metagenomic DNA on amplification of S. marcescens
DNA, a qPCR assay was performed using metagenomic DNA from BAL samples spiked
with template gDNA. In brief, the SM1_FR primer pair was used to detect S. marcescens
gDNA of varying concentrations when spiked with 200 ng of non-target DNA from five
BAL DNA extracts. Purified S. marcescens gDNA was used in the construction of
calibration curves to assess the quality of the DNA (Figure 19).
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Figure 19. Calibration curve for S. marcescens DNA amplification using SM1_FR
primers. Log of starting quantities is plotted against mean Ct values of amplification of
purified S. marcescens gDNA. The blue symbols represent the triplicate PCR
amplification of the standard DNA samples (1, 0.2, 0.04, 0.008, and 0.002 ng/µL
concentrations). Linear regression analysis yielded the reported slope and R2 values.
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The Ct values varied with the amount of template DNA added. Figure 20
illustrates the results of qPCR amplification of each sample spiked with BAL at a given
concentration of S. marcescens gDNA using the SM1_FR primer pair. Upon visual
inspection, the lower template concentration (Figure 20, Panel C) seems to have generally
higher mean Ct values compared to the higher concentration (Figure 20, Panel A/B), as
expected. Additionally, all the samples spiked with BAL DNA (with the exception of
BAL 2 and BAL 3 in panel B) seem to have different mean Ct values as compared to the
control. To determine the significance of these differences, statistical tests were
performed.
A one-way ANOVA was conducted to compare mean Ct values of the unspiked
control and the samples spiked with BAL DNA. A significant effect on the mean Ct
values was seen between almost all samples (p < 0.05). Post-hoc comparisons using the
Tukey HSD test indicated that the mean Ct value of the 0.2 ng control (29.14 ± 0.32) was
significantly lower than the mean Ct value of sample spiked with DNA from BAL 1
(30.99 ± 0.28, p-value = 4.12 x 10-5), BAL 3 (31.99 ± 0.06, p-value = 4 x 10-7), BAL 4
(30.46 ± 0.37, p-value = 0.001), and BAL 5 (32.22 ± .18, p= 2 x 10-7). However, no
statistically significant difference was observed between the mean Ct values of the 0.2 ng
control (29.14 ± 0.32) and the BAL 2 spiked sample (28.66 ± 0.34, p-value = 0.34).
For 0.04 ng of S. marcescens DNA, a significant effect on the mean Ct values was
seen between almost all samples (p < .05). Post-hoc comparisons using the Tukey HSD
test indicated that the mean Ct value of the 0.04 ng control (31.88 ± 0.18) was
significantly lower than the mean Ct value of samples spiked with DNA from BAL 3
(35.16 ± 0.22, p-value = 0.00014), BAL 4 (33.21 ± 0.28, p-value = 0.0101), and BAL 5
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(35.36 ± 0.16, p= 8.09 x 10-5). However, no statistically significant difference was
observed between the mean Ct values of the 0.04 ng control (31.88 ± 0.18) and samples
spiked with BAL 1 (33.15 ± 1.001, p-value = 0.113) or BAL 2 (31.68 ± 0.34, p-value =
0.9969).
The smallest amount S. marcescens DNA template (0.008 ng), the same
significant effect on the mean Ct values was seen between almost all samples (p < 0.05).
Post-hoc comparisons using the Tukey HSD test indicated that the mean Ct value of the
0.008 ng unspiked control (33.59 ± .024) was significantly lower than the mean Ct value
of samples spiked with DNA from BAL 1 (36.49 ± 0.05, p-value = 0.00), BAL 3 (37.06 ±
0.08, p-value = 0.00), BAL 4 (35.94 ± 0.32, p-value = 0.00), and BAL 5 (37.97 ± 0.16, pvalue = 0.00). However, similarly to the higher concentrations, no significant difference
was observed between the mean Ct values of the 0.008 ng control (29.14 ± .032) and the
BAL 2 spiked sample (33.80 ± 0.21, p-value = 0.6497).
A melt curve analysis was also performed post-amplification (Figure 21). The
curve indicates the major amplicon disassociation of all samples KF9<8K.D U 
No lingering fluorescence is detected after the major amplicon dissociation Tm (Figure
21).
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Figure 21. Melt-curve analysis using SM1_FR primers and spiked S. marcescens gDNA.
The normalized reporter fluorescence (Rn) values are plotted against temperature.
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DISCUSSION

Real-time qPCR is an indispensable tool that can be used to identify the presence
of specific bacteria in a variety of environments and conditions. As such, it has been a
useful tool in the field of forensics to detect harmful bacterial agents. The qPCR method
has been used primarily for detection of indicatory virulence plasmids of biological
warfare agents such as B. anthracis and Y. pestis, as well as surrogate organisms such as
B. thuringiensis and S. marcescens (Porcar and Juarez-Perez 2003; Saikaly et al. 2007;
Skottman et al. 2007; Janse et al. 2010). The work presented here addresses the need for
additional qPCR assays targeting the bacterial chromosome. In this study, I have
designed species-specific primer pairs for the detection of B. thuringiensis and S.
marcescens and confirmed their specificity and sensitivity.

Primer Design Workflow Yields Effective Primer Pairs

There is limited research on chromosomal targets for B. thuringiensis and S.
marcescens detection. To date most species-specific detection of these strains relies on
targeting markers on plasmids (Porcar and Juarez-Perez 2003; Saikaly et al. 2007;
Skottman et al. 2007; Janse et al. 2010). This is less desirable as the copy number of
plasmid can vary from strain to strain (Janse et al. 2010). Furthermore, in some
attenuated or genetically altered strains, one or more virulence plasmids can be absent,
and subsequently go undetected.
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To circumvent this problem, primers targeting the chromosome were designed de
novo for this study using the workflow as described in the materials and methods (Figure
8). Three primer pairs were designed specifically in this study: BTK1_FR, BTK2_FR,
and SM1_FR. The BTK1_FR and BTK2_FR primers target genes encoding a
hypothetical protein and a FAD-dependent oxidase, respectively. These two genes are
several thousand base pairs apart (Table 4). The SM1_FR primer recognizes the gyrB
gene, similar to the published SM2_FR primer (Saikaly et al. 2007). In fact, the
amplicons overlap (Table 4). The similarity between the published primer (SM2_FR) and
the de novo primer (SM1_FR) validated the primer design processes used in this study.
The workflow developed in this study is particularly valuable as it bypasses the
need to manually acquire sequences and perform alignments by utilizing the Insignia
program (Phillippy et al. 2009). With this program, there is no need to specify target area,
rather it allows for searching of potentially new specifies-specific markers. Moreover,
this design can be used to develop species-specific PCR primers for any organism that
has genomic sequence information in the Insignia database.

BTK1_FR Amplifies B. thuringiensis gDNA Most Effectively

The BTK1_FR and BTK2_FR primer pairs were extremely specific, as they did
not amplify B. cereus, B. megaterium, B. subtilis, S. marcescens, P. aeruginosa, or H.
influenzae DNA (Figure 10). Although no amplification was expected in the case of S.
marcescens, P. aeruginosa, or H. influenzae, the absence of amplification of the B.
cereus group organisms is an important finding. Discrimination of the phylogenetically
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similar B. cereus group organisms is generally dealt with by targeting particular plasmids,
which differ between organisms, or through sequencing of conserved polymorphic
markers like 16S rRNA genes (Sacchi et al. 2002; Bavykin et al. 2004). The results from
this study indicate that the development of species-specific chromosomal primers for B.
thuringiensis is feasible with careful primer design and target selection.
Both the BTK1_FR and BTK2_FR primers specifically amplify the target DNA
(Figure 10). However, the latter appears to be less specific when the template
concentration is increased (Figure 9) as PCR results in two different amplicons (two faint
bands; Figure 9). Non-specific amplification could be due to the excessive amount of
template DNA, the binding to sequences in other Bacillus in the mixture, or
contamination of a specific aliquot of the primer mix used in that particular reaction.
The absence of non-specific amplification with BTK1_FR (Figure 10) even with
very low template concentration demonstrates that this primer is more specific and
sensitive than BTK2_FR. The superiority of the BTK1_FR primers is supported by the
qPCR data, which shows a significant decrease in mean Ct value in comparison to
BTK2_FR (Figure 11). Apart from the similar Tm values for both primer pairs, the
difference in the melt curve peak heights indicates significantly decreased amount of end
product in the BTK2_FR amplification as compared to the BTK1_FR. The exact cause of
this sensitivity discrepancy between the two primer pairs is unclear. Most likely, at
reasonable template concentrations, the BTK2_FR primers are simply be less efficient at
binding their target than the BTK1_FR primers, resulting in lower Ct values and reduced
total amount of amplification products.
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SM1_FR Amplifies S. marcescens gDNA Most Effectively

SM1_FR and SM2_FR primer pairs show effective and specific amplification of
S. marcescens gDNA (Figure 9, 10). The similarity in primer performance was also
observed in the qPCR assay. At both concentrations of input template DNA, both primers
had nearly identical mean Ct values (Figure 13) and Tm values (Figure 14).

The

similarity and the sensitivity of amplifications of S. marcescens gDNA with the SM1_FR
and SM2_FR primer pairs target the same gene, gyrB, encoding DNA gyrase (Dauga
2002; Saikaly et al. 2007). A closer look at the melting curve reveals some differences in
the curve shape, particularly a shoulder in the curve for the SM2_FR amplification
products (Figure 14). This small shoulder (consistent between both template
concentrations) could indicate the presence of a second amplicon, due to its small size
and its Tm occurring at a lower temperature than the main amplicon. This peak is absent
in the SM1_FR melt curve, suggesting the lack of any secondary product formation.
Thus, SM1_FR primer pair designed in this study is superior to the published SM2_FR
primer pair.

The Presence of Metagenomic DNA Reduces Sensitivity of qPCR Assays

The sensitivity of the primer pairs was tested by spiking metagenome from BAL
samples with varying amount of target genomic DNA. Although the composition of
metagenome in each BAL sample is unknown, the amount of DNA was normalized to
200 ng. The sensitivity was reduced in the presence four out of the five BAL samples in
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every spike concentration B. thuringiensis and S. marcescens. As previously shown
where increasing concentrations of background DNA affected amplification performance
by hindering access to the target sequences (Ludwig and Schleifer 2000). This effect of
‘crowding’ the polymerase with non-target DNA may result in decreased efficiency due
to stochastic effects, effectively reducing the probability of target sequences being found.
The ratio of the template to the background DNA was crucial to observe the changes in
assay sensitivity reported in this study. If the ratio of spike to background DNA was
small (i.e. low [template DNA] and low [background DNA] or visa versa), there was no
significant loss in sensitivity, suggesting that the background was not sufficient to
influence template amplification. Alternatively, with a large ratio of spike to background
DNA (i.e. low [template DNA] and high [background DNA]), the difference in
sensitivity becomes more significant.
The significant decrease in sensitivity observed could be due to the presence of
PCR inhibitors in the metagenomic DNA, which was not directly tested in this study.
However, the likelihood of potential PCR inhibitors carrying over through the BAL DNA
extraction process is very small, due to the silica-bead based extraction method used.
This technique, which allows binding of DNA to beads and subsequent washing of
contaminants, retains fewer PCR inhibitors than other methods (e.g. organic
phenol/chloroform extraction, chelex extraction). Additionally, the presence of PCR
inhibitors would have likely caused shift in the melt curve analyses, which was not
observed. The BAL DNA from all five samples was successfully amplified using 16S
MJ68_FR primers in another study (data not shown), indicating that the DNA was
amplifiable and did not contain inhibitory compounds.
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Of the five BAL samples, BAL2 consistently showed no difference in
amplification sensitivity compared to the standards. This was conserved through both the
B. thuringiensis and S. marcescens assays. A number of issues could account for this lack
of difference. Although unlikely, the quantification of the DNA could have been
incorrect, presumably reporting higher values than the actual concentration. Although the
method of quantification used is not the most accurate or sensitive (UV
spectrophotometry), it is rarely an issue at such high concentrations of DNA using proper
blanks. Quantification errors would not only affect BAL2, as all other DNA
quantification was performed with the same method.
BAL2 could also potentially contain DNA from B. thuringiensis and S.
marcescens, increasing the overall concentration of template DNA in the mixed sample.
This is highly doubtful due to the low probability of finding B. thuringiensis and S.
marcescens in the lungs, much less in the same lung sample. Alternatively, non-specific
binding could be occurring due to DNA sequences present within the extracted BAL
DNA. Although no obvious additional amplicons were seen, (Figure 18, Figure 22)
repeated analysis of the melt curve did not reveal non-specific amplification.
Degradation of BAL2 DNA could offset the inhibitory effect observed with other
spiked BAL samples. Repeated freeze-thaw cycles during experimentation or the
incomplete removal of exonuclease enzymes during extraction could cause such
degradation (Grecz et al. 1980; Cohen 1993). Research shows that while the degradation
of DNA does skew some methods of DNA quantification, spectrophotometric
measurements of DNA content are not effected (Sedlackova et al. 2013). The physical
hindrance of PCR primers and polymerase from binding their target sequences could be
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decreased with smaller metagenomic BAL2 DNA fragments, thereby not affecting
sensitivity, as was observed.

B. thuringiensis and S. marcescens Are Detectable in the Complex Mixture

The BAL DNA caused a significant reduction in sensitivity in four out of the five
spiked samples, indicated by a significant increase in Ct values (except BAL 2) compared
to the unspiked control (Figure 21). Although the assay sensitivity decreased
considerably, both B. thuringiensis and S. marcescens were successfully amplified,
suggesting the primer-pairs designed are very specific. B. thuringiensis DNA was
detected even at 0.04 ng of template (equivalent to approximately 2000 cells) (Figure 16,
17). The absence of reliable amplification with 0.008 ng of B. thuringiensis DNA is
likely due to the lower sensitivity as compared to the SM1_FR S. marcescens assay. The
small amount of non-specific amplification, indicated by the continued melting of several
samples after the Tm in the dissociation curve (Figure 18), could also decrease sensitivity.
The sensitivity of the SM1_FR primer pair is corroborated by the successful
amplification of S. marcescens DNA at 0.008 ng of template (approximately 1000 cells),
even in the presence of BAL DNA.

Concluding Remarks

The research reported in this thesis includes several valuable and interesting
findings. Notably, the developed global approach to primer design can be used in a
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number of different applications to develop species-specific primers for many organisms.
Additionally, the establishment of novel species-specific primers for B. thuringiensis and
S. marcescens provides additional options for researchers and scientists using PCR for
bacterial detection. This work is particularly pertinent due to the use of clinical lung
sample DNA as the background matrix, which is a main route-of-entry of dangerous
biological warfare agents like B. anthracis and Y. pestis. The application of the assays
extends past microbial forensics, as any field where detection of bacterial either species
in a complex matrix is required can benefit directly from these assays.
Furthermore, the biases introduced by complex background DNA were
quantitatively tested in this research. While this work dealt with detection of specific
bacteria in a specific type of background, the knowledge of the potential biases
introduced by environmental or clinical samples is important, and should taken into
account when designing assays. It is also crucial to note the situations in which these
reported sensitivity biases are significant. The discrepancy in sensitivity could be
irrelevant when large amounts of template sample are present. Contrastingly, the bias
could be relevant in clinical applications such as early testing for the presence of B.
anthracis within the lung, before they present in the bloodstream. In such an instance, the
resident microbial community would surround samples containing the target organism.
Environmental applications such as bio-monitoring of water or air supplies could be
affected as well. If the background matrix could significantly inhibit detection of the
target, the pathogen could go undetected as a false negative.
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Future Directions

Sequencing of PCR products. Beyond the melt curve analysis, definitive
verification of products produced from both the B. thuringiensis and S. marcescens could
be accomplished using direct sequencing or next-generation sequencing methods. In this
study, sequencing could be used in two ways. First, sequencing the products from
amplifications with pure genomic DNA as the template can unequivocally confirm the
amplification of the desired product. Sequencing of the PCR products from the spiked
DNA templates would help identify potential unintended amplicons, particularly in the
case of amplifications with BTK1_FR primers.

Expanded strain panel. Future experiments or additions could be performed to
improve and corroborate this work. Firstly, a larger panel of strains for primer specificity
testing could be assembled. A more extensive panel would likely include several Serratia
spp., alternative strains of B. thuringiensis and S. marcescens, as well as more common
lung bacteria, such as Staphylococcus, Streptococcus, Haemophilus, and Prevotella spp.
(Erb-Downward et al. 2011). The testing of the designed primers against this larger panel
would allow for more confidence in the specificity of the primers reported in this study.

Additional background samples. Increasing the number of BAL samples used
could also afford more latitude to the research. The five BAL samples used were
randomly selected from a cohort of 60 subjects. Increasing the number of BAL samples
used to 15 or 20, could improve the study. Knowing the microbial composition of the

73

BAL samples can reveal potential effects of specific groups of bacteria on the sensitivity
of the designed assays. Additionally, the inclusion of environmental samples such as soil
samples could provide an even more rigorous test for the assays, as soil could contain
other types of organisms more likely to cross-react with the designed primers.

Whole-cell spiking experiment. Lastly, for this research, DNA was extracted
from the individual bacteria separately from the BAL samples, and then mixed together.
This method was chosen due to the ability to have greater control over the exact DNA
concentrations in the final mixture. However, experiments that involved mixing whole
bacterial cells with BAL samples, then extracting total DNA would be more analogous to
a real life sample testing. A cell level spiking experiment could also account for
differences in extraction efficiencies by using internal controls.
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